UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended June 30, 2008
OR
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Commission file number: 001-14003
OMEGA PROTEIN CORPORATION
(Exact name of Registrant as specified in its charter)
|
|
|
State of Nevada
|
|
76-0562134
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
2105 City West Blvd., Suite 500
Houston, Texas
|
|
77042-2838
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (713) 623-0060
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter
period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
x
No
¨
.
Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of large accelerated filer, accelerated filer and smaller reporting
company in Rule 12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer
|
|
¨
|
|
Accelerated filer
|
|
x
|
|
|
|
|
Non-accelerated filer
|
|
¨
|
|
Smaller reporting company
|
|
¨
|
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act)
Yes
¨
No
x
.
Number of shares outstanding of the Registrants Common Stock, par value $0.01 per share, on August 4, 2008: 18,565,205.
OMEGA PROTEIN CORPORATION
TABLE OF CONTENTS
2
OMEGA PROTEIN CORPORATION
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEET
(Dollars in thousands, except per share amounts)
PART I. FINANCIAL INFORMATION
Item 1.
|
Financial Statements and Notes
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
2008
|
|
|
December 31,
2007
|
|
ASSETS
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
23,813
|
|
|
$
|
19,292
|
|
Receivables, net
|
|
|
21,239
|
|
|
|
16,051
|
|
Inventories
|
|
|
76,739
|
|
|
|
70,852
|
|
Prepaid expenses and other current assets
|
|
|
2,430
|
|
|
|
1,456
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
124,221
|
|
|
|
107,651
|
|
Other assets, net
|
|
|
3,989
|
|
|
|
3,344
|
|
Deferred tax assets, net
|
|
|
|
|
|
|
175
|
|
Property, plant and equipment, net
|
|
|
104,472
|
|
|
|
96,659
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
232,682
|
|
|
$
|
207,829
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Current maturities of long-term debt
|
|
$
|
6,983
|
|
|
$
|
6,283
|
|
Current portion of capital lease obligation
|
|
|
137
|
|
|
|
|
|
Accounts payable
|
|
|
3,558
|
|
|
|
2,459
|
|
Accrued liabilities
|
|
|
21,991
|
|
|
|
15,067
|
|
Deferred tax liabilities, net
|
|
|
1,423
|
|
|
|
381
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
34,092
|
|
|
|
24,190
|
|
Long-term debt, net of current maturities
|
|
|
55,092
|
|
|
|
58,976
|
|
Capital lease obligation, net of current portion
|
|
|
890
|
|
|
|
|
|
Interest rate swap liability, net of current portion
|
|
|
31
|
|
|
|
459
|
|
Pension liabilities, net
|
|
|
4,755
|
|
|
|
5,749
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
94,860
|
|
|
|
89,374
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
Preferred stock, $0.01 par value; 10,000,000 authorized shares; none
issued
|
|
|
|
|
|
|
|
|
Common Stock, $0.01 par value; 80,000,000 authorized shares; 18,471,123 and 17,453,702 shares issued and outstanding at June 30, 2008 and
December 31, 2007, respectively
|
|
|
185
|
|
|
|
175
|
|
Capital in excess of par value
|
|
|
112,185
|
|
|
|
101,865
|
|
Retained earnings
|
|
|
32,057
|
|
|
|
23,435
|
|
Accumulated other comprehensive loss
|
|
|
(6,605
|
)
|
|
|
(7,020
|
)
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
137,822
|
|
|
|
118,455
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$
|
232,682
|
|
|
$
|
207,829
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the unaudited condensed consolidated financial
statements.
3
OMEGA PROTEIN CORPORATION
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME
(Dollars in thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30,
|
|
|
Six Months Ended
June 30,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
Revenues
|
|
$
|
47,128
|
|
|
$
|
37,094
|
|
|
$
|
83,237
|
|
|
$
|
68,223
|
|
Cost of sales
|
|
|
31,202
|
|
|
|
28,299
|
|
|
|
59,053
|
|
|
|
53,165
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
15,926
|
|
|
|
8,795
|
|
|
|
24,184
|
|
|
|
15,058
|
|
|
|
|
|
|
Selling, general, and administrative expense
|
|
|
3,988
|
|
|
|
3,342
|
|
|
|
7,663
|
|
|
|
8,179
|
|
Research and development expense
|
|
|
332
|
|
|
|
179
|
|
|
|
650
|
|
|
|
387
|
|
(Gain) loss on disposal of assets
|
|
|
(32
|
)
|
|
|
184
|
|
|
|
185
|
|
|
|
184
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
11,638
|
|
|
|
5,090
|
|
|
|
15,686
|
|
|
|
6,308
|
|
Interest income
|
|
|
145
|
|
|
|
56
|
|
|
|
299
|
|
|
|
134
|
|
|
|
|
|
|
Interest expense
|
|
|
(986
|
)
|
|
|
(1,269
|
)
|
|
|
(2,197
|
)
|
|
|
(2,940
|
)
|
Loss resulting from debt refinancing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,024
|
)
|
Other income (expense), net
|
|
|
(68
|
)
|
|
|
(69
|
)
|
|
|
(124
|
)
|
|
|
(171
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
10,729
|
|
|
|
3,808
|
|
|
|
13,664
|
|
|
|
307
|
|
|
|
|
|
|
Provision for income taxes
|
|
|
4,019
|
|
|
|
1,293
|
|
|
|
5,042
|
|
|
|
104
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
6,710
|
|
|
|
2,515
|
|
|
|
8,622
|
|
|
|
203
|
|
|
|
|
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recognized actuarial net loss, net of tax benefit of $66, $142, $132 and $211, respectively
|
|
|
127
|
|
|
|
204
|
|
|
|
255
|
|
|
|
408
|
|
|
|
|
|
|
Interest rate swap adjustment, net of tax expense of $325, $36, $82 and $36, respectively
|
|
|
632
|
|
|
|
71
|
|
|
|
160
|
|
|
|
71
|
|
Foreign currency translation adjustment, net of $0, $4, $0 and $4, respectively
|
|
|
|
|
|
|
8
|
|
|
|
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
$
|
7,469
|
|
|
$
|
2,798
|
|
|
$
|
9,037
|
|
|
$
|
690
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share
|
|
$
|
0.37
|
|
|
$
|
0.15
|
|
|
$
|
0.48
|
|
|
$
|
0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding
|
|
|
18,328
|
|
|
|
16,598
|
|
|
|
17,925
|
|
|
|
16,465
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share
|
|
$
|
0.36
|
|
|
$
|
0.14
|
|
|
$
|
0.47
|
|
|
$
|
0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares and potential common share equivalents outstanding
|
|
|
18,703
|
|
|
|
17,351
|
|
|
|
18,358
|
|
|
|
17,280
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the unaudited condensed consolidated financial
statements.
4
OMEGA PROTEIN CORPORATION
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended
June 30,
|
|
|
|
2008
|
|
|
2007
|
|
Cash flow (used in) provided by operating activities:
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
8,622
|
|
|
$
|
203
|
|
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
6,439
|
|
|
|
6,832
|
|
Loss resulting from debt refinancing
|
|
|
|
|
|
|
2,151
|
|
Loss on disposal of assets, net
|
|
|
185
|
|
|
|
184
|
|
Provisions for losses on receivables
|
|
|
24
|
|
|
|
15
|
|
Share based compensation
|
|
|
141
|
|
|
|
164
|
|
Deferred income taxes
|
|
|
1,135
|
|
|
|
(1,218
|
)
|
Changes in assets and liabilities:
|
|
|
|
|
|
|
|
|
Receivables
|
|
|
(5,264
|
)
|
|
|
(9,453
|
)
|
Inventories
|
|
|
(5,887
|
)
|
|
|
(2,967
|
)
|
Prepaid expenses and other current assets
|
|
|
(974
|
)
|
|
|
(1,060
|
)
|
Other assets
|
|
|
(1,288
|
)
|
|
|
(684
|
)
|
Accounts payable
|
|
|
1,099
|
|
|
|
537
|
|
Accrued liabilities
|
|
|
6,738
|
|
|
|
5,737
|
|
Pension liability, net
|
|
|
(739
|
)
|
|
|
(680
|
)
|
Other, net
|
|
|
|
|
|
|
(33
|
)
|
|
|
|
|
|
|
|
|
|
Total adjustments
|
|
|
1,609
|
|
|
|
(475
|
)
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities
|
|
|
10,231
|
|
|
|
(272
|
)
|
|
|
|
|
|
|
|
|
|
Cash flow (used in) provided by investing activities:
|
|
|
|
|
|
|
|
|
Proceeds from disposition of assets
|
|
|
94
|
|
|
|
|
|
Proceeds from insurance companies, hurricanes
|
|
|
|
|
|
|
6,549
|
|
Capital expenditures
|
|
|
(12,798
|
)
|
|
|
(4,770
|
)
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by investing activities
|
|
|
(12,704
|
)
|
|
|
1,779
|
|
|
|
|
|
|
|
|
|
|
Cash flow provided by (used in) financing activities:
|
|
|
|
|
|
|
|
|
Principal payments of long-term debt
|
|
|
(3,184
|
)
|
|
|
(50,975
|
)
|
Principal payments of capital lease obligation
|
|
|
(11
|
)
|
|
|
|
|
Debt issuance costs
|
|
|
|
|
|
|
(723
|
)
|
Proceeds from borrowings
|
|
|
|
|
|
|
43,349
|
|
Proceeds from stock options exercised
|
|
|
8,248
|
|
|
|
1,465
|
|
Tax effect of stock options exercised
|
|
|
1,941
|
|
|
|
1,252
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
6,994
|
|
|
|
(5,632
|
)
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
|
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
4,521
|
|
|
|
(4,117
|
)
|
Cash and cash equivalents at beginning of year
|
|
|
19,292
|
|
|
|
7,993
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
$
|
23,813
|
|
|
$
|
3,876
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the unaudited condensed consolidated financial
statements.
5
OMEGA PROTEIN CORPORATION
UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY
(Dollars and shares in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital
|
|
|
|
Accumulated
Other
|
|
|
Total
|
|
|
Common Stock
|
|
Excess of
|
|
Retained
|
|
Comprehensive
|
|
|
Stockholders
|
|
|
Shares
|
|
Amount
|
|
Par Value
|
|
Earnings
|
|
Loss
|
|
|
Equity
|
Balance at December 31, 2007
|
|
17,454
|
|
$
|
175
|
|
$
|
101,865
|
|
$
|
23,435
|
|
$
|
(7,020
|
)
|
|
$
|
118,455
|
Issuance of common stock
|
|
1,017
|
|
|
10
|
|
|
8,379
|
|
|
|
|
|
|
|
|
|
8,389
|
Tax benefit from exercise of stock options
|
|
|
|
|
|
|
|
1,941
|
|
|
|
|
|
|
|
|
|
1,941
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
8,622
|
|
|
|
|
|
|
8,622
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recognized actuarial net loss, net of tax benefit of $132
|
|
|
|
|
|
|
|
|
|
|
|
|
|
255
|
|
|
|
255
|
Interest rate swap adjustment, net of tax expense of $82
|
|
|
|
|
|
|
|
|
|
|
|
|
|
160
|
|
|
|
160
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
8,622
|
|
|
415
|
|
|
|
9,037
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at June 30, 2008
|
|
18,471
|
|
$
|
185
|
|
$
|
112,185
|
|
$
|
32,057
|
|
$
|
(6,605
|
)
|
|
$
|
137,822
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the consolidated financial statements.
6
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1. Significant Accounting Policies
Summary Of
Operations And Basis Of Presentation
Business Description
Omega Protein Corporation (Omega or the Company) produces and markets a variety of products produced from menhaden (a herring-like species of fish found in commercial quantities in the U.S.
coastal waters of the Atlantic Ocean and Gulf of Mexico), including regular grade and value-added specialty fish meals, crude and refined fish oils and fish solubles. The Companys fish meal products are primarily used as a protein ingredient
in animal feed for swine, cattle, aquaculture and household pets. Fish oil is utilized for animal and aquaculture feeds, industrial applications, as well as for additives to human food products and dietary supplements. The Companys fish
solubles are sold primarily to livestock feed manufacturers, aquaculture feed manufacturers and for use as an organic fertilizer.
Basis of
Presentation
These interim financial statements of Omega have been prepared in accordance with accounting principles generally
accepted in the United States of America for interim financial information, the instructions to Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information and footnote disclosures normally provided have been
omitted. The interim financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2007. The year end condensed balance sheet data was derived from audited financial statements, but does
not include all disclosures required by accounting principles generally accepted in the United States of America.
In the opinion of
management the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the Companys consolidated financial position as of
June 30, 2008, and the results of its operations for the three and six month periods ended June 30, 2008 and its cash flows for the six month periods ended June 30, 2008 and 2007. Operating results are not necessarily indicative of
the results that may be expected for the year ending December 31, 2008.
Consolidation
The consolidated financial statements include the accounts of Omega and its wholly owned subsidiaries. All significant intercompany accounts and
transactions have been eliminated in consolidation.
Financial Statement Preparation
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to
make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Companys financial statements and the accompanying notes and the reported amounts
of revenues and expenses during the reporting period. Actual amounts, when available, could differ from those estimates and those differences could have a material affect on the financial statements.
7
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
Hurricane Losses and Insurance Recoveries
On
August 29, 2005, the Companys Moss Point, Mississippi fish processing facility and adjacent shipyard were severely damaged by Hurricane Katrina. On September 25, 2005, the Companys Cameron, Louisiana and Abbeville, Louisiana
fish processing facilities were also severely damaged by Hurricane Rita. Each of these facilities was non-operational immediately after these weather events. Operations at the Moss Point fish processing facility, the Abbeville fish processing
facility and the shipyard were re-established in mid-October, 2005, but at reduced processing capabilities. These two plants became fully operational prior to the start of the 2006 Gulf fishing season. Operations at the Cameron fish processing
facility were re-established in June 2006, but at reduced processing capabilities. The Cameron facility became fully operational in September 2006.
The direct impact of the two hurricanes upon the Company was a loss of physical inventories and physical damage to the plants. The interruption of processing capabilities caused the Company to address the impact of abnormal downtime of its
processing facilities, which resulted in the immediate recognition of costs which would ordinarily have been captured as inventory costs. See Note 12 for additional information pertaining to these losses.
The Company maintains insurance coverage for a variety of these damages, most notably property, inventory and vessel insurance. The nature and extent of
the insurance coverage varies by line of policy and the Company has previously recorded insurance recoveries as long-term receivables within other assets based on estimates of probable recoveries.
In order to facilitate the insurance recovery process, on July 28, 2006, the Company filed a lawsuit against its property insurance carriers,
Lexington Insurance Company and RSUI Indemnity Company, in the U.S. District Court for the Western District of Louisiana, alleging breach of contract and bad faith based on the insurance carriers failure to pay amounts due to the Company under
its property insurance policies for damages sustained from Hurricanes Katrina and Rita in the third quarter of 2005. The Company settled its lawsuit with its primary property insurance carrier, Lexington Insurance Company, for a total of $19.8
million during the third quarter of 2007. Of the $19.8 million, $12.0 million was previously recorded as a receivable and was fully received as of September 30, 2007, $3.3 million was paid to outside legal counsel in connection with the
settlement and $4.5 million was recognized during the third quarter of 2007 as insurance recoveries relating to natural disaster in the statement of operations and comprehensive income and was received as of December 31, 2007. In addition, the
Company settled its lawsuit with its secondary property insurance carrier, RSUI Indemnity Company, for a total of $9.2 million during the fourth quarter of 2007. Of the $9.2 million, $0.7 million was advanced during the third quarter of 2007 and
recognized as insurance recoveries relating to natural disaster in the statement of operations and comprehensive income, $3.0 million was paid to outside legal counsel in connection with the settlement during the fourth quarter of 2007 and $5.5
million was recognized and received during the fourth quarter of 2007 as insurance recoveries relating to natural disaster in the statement of operations and comprehensive income. The Company still has a pending lawsuit against its insurance broker
alleging negligent procurement, negligent misrepresentation, breach of contract and violations of Texas Insurance and Consumer laws.
Revenue
Recognition
The Company derives revenue principally from the sales of a variety of protein and oil products derived from menhaden.
The Company recognizes revenue for the sale of its products when title and rewards of ownership to its products are transferred to the customer.
8
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
Cash and Cash Equivalents
The Company
considers cash in banks and short-term investments with original maturities of three months or less as cash and cash equivalents.
Allowances for
Doubtful Accounts
The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of the
Companys customers to make required payments. The Company considers the following factors when determining if collection is reasonably assured: customer credit worthiness, past transaction history with the customer, and changes in customer
payment terms. If the Company has no previous experience with the customer, the Company typically obtains reports from credit organizations to ensure that the customer has a history of paying its creditors. The Company may also request financial
information, including financial statements or other documents (e.g., bank statements), or may obtain a letter of credit from the customer to ensure that the customer has the means of making payment. If the financial condition of the Companys
customers were to deteriorate, adversely affecting their ability to make payments, additional allowances would be required.
Inventories
Inventory is stated at the lower of cost or market. The Companys fishing season runs from mid-April to the first of November in the
Gulf of Mexico and from the beginning of May into December in the Atlantic. Government regulations generally preclude the Company from fishing during the off-seasons.
The Companys inventory cost system considers all costs associated with an annual fish catch and its processing, both variable and fixed, including both costs incurred during the off-season and during the fishing
season. The Companys costing system allocates cost to inventory quantities on a per unit basis as calculated by a formula that considers total estimated inventoriable costs for a fishing season (including off-season costs) to total estimated
fish catch and the relative fair market value of the individual products produced. The Company adjusts the cost of sales, off-season costs and inventory balances at the end of each quarter based on revised estimates of total inventoriable costs and
fish catch. The Companys lower-of-cost-or-market-value analyses at year-end and at interim periods compare the total estimated per unit production cost of the Companys expected production to the projected per unit market prices of the
products. The impairment analyses involve estimates of, among other things, future fish catches and related costs, and expected commodity prices for the fish products as well as projected purchase commitments from customers. These estimates, which
management believes are reasonable and supportable, involve estimates of future activities and events which are inherently imprecise and from which actual results may differ materially.
Any costs incurred during abnormal downtime related to activity at the Companys plants are charged to expense as incurred.
During the off-seasons, in connection with the upcoming fishing seasons, the Company incurs costs (i.e., plant and vessel related labor, utilities, rent,
repairs, and depreciation) that are directly related to the Companys infrastructure. These costs accumulate in inventory and are applied as elements of the cost of production of the Companys products throughout the fishing season ratably
based on the Companys monthly fish catch and the expected total fish catch for the season.
Insurance
The Company carries insurance for certain losses relating to its vessels and Jones Act liabilities for employees aboard its vessels. The Company provides
reserves for those portions of the annual aggregate deductible for which
9
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
the Company remains responsible by using an estimation process that considers Company-specific and industry data as well as managements experience,
assumptions and consultation with counsel, as these reserves include estimated settlement costs. Managements current estimated range of liabilities related to such cases is based on claims for which management can estimate the amount and range
of loss. For those claims where there may be a range of loss, the Company has recorded an estimated liability inside that range, based on managements experience, assumptions and consultation with counsel. The process of estimating and
establishing reserves for these claims is inherently uncertain and the actual ultimate net cost of a claim may vary materially from the estimated amount reserved. There is some degree of inherent variability in assessing the ultimate amount of
losses associated with these claims due to the extended period of time that transpires between when the claim might occur and the full settlement of such claims. This variability is generally greater for Jones Act claims by vessel employees. The
Company continually evaluates loss estimates associated with claims and losses as additional information becomes available and revises its estimates. Although management believes estimated reserves related to these claims are adequately recorded, it
is possible that actual results could significantly differ from the recorded reserves, which could materially impact the Companys results of operations, financial position and cash flow.
The Company is primarily self-insured for health insurance. The Company purchases individual stop loss coverage with a large deductible. As a result, the
Company is primarily self-insured for claims and associated costs up to the amount of the deductible, with claims in excess of the deductible amount being covered by insurance. Expected claims estimates are based on health care trend rates and
historical claims data; actual claims may differ from those estimates. The Company evaluates its claims experience related to this coverage with information obtained from its risk management consultants.
Assumptions used in preparing these insurance estimates are based on factors such as claims settlement patterns, claim development trends, claim
frequency and severity patterns, inflationary trends and data reasonableness. Together these factors will generally affect the analysis and determination of the best estimate of the projected ultimate claim losses. The results of these
evaluations are used to both analyze and adjust the Companys insurance loss reserves.
Advertising Costs
The costs of advertising are expensed as incurred in accordance with Statement of Position 93-7 Reporting on Advertising Costs.
Research and Development
Costs incurred in
research and development activities are expensed as incurred.
Call Options
The Company does not enter into financial instruments for trading or speculative purposes. The Company purchased natural gas call options in March 2008
for $67,000 to manage its exposure to rising natural gas prices. The call options gave the Company the right to purchase natural gas at a price of $10.50 per MMBTU between April 1, 2008 and June 30, 2008.
For the three and six month periods ended June 30, 2008, the Company recorded gains in the unallocated inventory cost pool of $59,000 and $29,000,
respectively, related to the settlement of natural gas call options above the $10.50 option price.
10
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
Interest Rate Swap Agreements
The Company does
not enter into financial instruments for trading or speculative purposes. The Company entered into interest rate swap agreements to manage its cash flow exposure to interest rate changes with notional amounts as indicated below that are scheduled to
mature in March 2012. The swaps effectively convert all the Companys variable rate debt under the Term Loan (as defined below) to a fixed rate, without exchanging the notional principal amounts.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of Contract
|
|
Original
Notional
Amount
|
|
Contracted
Interest
Rate
|
|
|
Total Asset
(Liability) as of
June 30,
2008
|
|
|
Total Deferred
Tax Asset
(Liability) as of
June 30, 2008
|
|
|
Notional
Amount as of
June 30, 2008
|
April 4, 2007
|
|
$
|
19,950,000
|
|
5.16
|
%
|
|
$
|
(630,800
|
)
|
|
$
|
214,500
|
|
|
$
|
18,453,800
|
February 7, 2008
|
|
|
10,237,500
|
|
3.36
|
%
|
|
|
111,000
|
|
|
|
(37,700
|
)
|
|
|
9,712,500
|
March 19, 2008
|
|
|
4,436,250
|
|
2.96
|
%
|
|
|
90,700
|
|
|
|
(30,800
|
)
|
|
|
4,208,700
|
As of June 30, 2008, the Company has recorded a long-term liability of $31,000, net of the
current portion of $398,000, to recognize the fair value of interest rate derivatives, and has also recorded a deferred tax asset of $146,000 associated therewith. The change in fair value from inception to June 30, 2008 is recorded in
other comprehensive income in the Companys consolidated financial statements. The following table illustrates the changes recorded, net of tax, in accumulated other comprehensive loss resulting from the interest rate swap
agreements.
|
|
|
|
|
|
|
(in thousands)
|
|
Balance at January 1, 2008
|
|
$
|
(442
|
)
|
Net gain/(loss), net of tax, reclassified into earnings
|
|
|
(85
|
)
|
Net change associated with current period swap transactions, net of tax
|
|
|
245
|
|
|
|
|
|
|
Balance at June 30, 2008
|
|
$
|
(282
|
)
|
|
|
|
|
|
The $282,000 reported in accumulated other comprehensive loss as of June 30, 2008 will be
reclassified to earnings on a quarterly basis through 2012, when the interest rate swaps expire. The amount to be reclassified to earnings during the next 12 months is expected to be approximately $398,000.
If, at any time, the swaps are determined to be ineffective, in whole or in part, due to changes in the interest rate swaps or underlying debt
agreements, the fair value of the portion of the interest rate swaps determined to be ineffective will be recognized as gain or loss in interest expense in the statement of operations for the applicable period.
Accounting for the Impairment of Long-Lived Assets
The Company evaluates at each balance sheet date the continued appropriateness of the carrying value of its long-lived assets, including its long-term receivables and property, plant and equipment, in accordance with Statement of Financial
Accounting Standards (SFAS) No. 144, Accounting for the Impairment or Disposals of Long-Lived Assets. The Company reviews long-lived assets for impairment when events or changes in circumstances indicate that the
carrying amount of any such assets or grouping of assets may not be recoverable. The Company has grouped certain assets together (primarily marine vessels) for impairment testing on a fleet basis. If indicators of impairment are present, management
evaluates the undiscounted cash flows estimated to be generated by those assets or grouping of assets compared to the carrying amount of those items. The net carrying value of assets or grouping of assets not recoverable is reduced to fair value.
The Company considers continued operating losses, or significant and long-term changes in business conditions, to be its primary indicators of potential impairment.
11
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
Income Taxes
The Company utilizes the
liability method to account for income taxes. This method requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of existing temporary differences between the financial reporting and tax reporting
basis of assets and liabilities, and operating loss and tax credits carryforwards for tax purposes. The Company records a valuation allowance to reduce the deferred tax assets to the amount that is more likely than not to be realized. The Company
believes that the deferred tax assets recorded as of June 30, 2008 are realizable through future reversals of existing taxable temporary differences and future taxable income. If the Company were to subsequently determine that it would be able
to realize deferred tax assets in the future in excess of the net recorded amount, an adjustment to deferred tax assets would increase earnings for the period in which such determination was made. The Company will continue to assess the adequacy of
the valuation allowance on a quarterly basis. Any changes to the estimated valuation allowance could be material to the consolidated financial condition and results of operations.
Property, Equipment and Depreciation
Property and equipment additions are recorded at cost.
Depreciation of property and equipment is computed by the straight-line method at rates expected to amortize the cost of property and equipment, net of salvage value, over their estimated useful lives. Estimated useful lives, determined at the date
of acquisition, of new assets acquired are based primarily on the review of existing property and equipment. Estimated useful lives are as follows:
|
|
|
|
|
Useful Lives
(years)
|
Fishing vessels and fish processing plants
|
|
15-20
|
Machinery, equipment, furniture and fixtures and other
|
|
3-10
|
Replacements and major improvements are capitalized and amortized over a period of 5 to 15 years,
and maintenance and repairs are charged to expense as incurred. Upon sale or retirement, the costs and related accumulated depreciation are eliminated from the accounts. Any resulting gains or losses are included in the statement of operations. The
Company capitalizes interest as part of the acquisition cost of a qualifying asset.
Interest is capitalized only during the period of time
required to complete and prepare the asset for its intended use. For the three and six month periods ended June 30, 2008 and 2007, the Company capitalized interest of approximately $74,200, $20,200, $128,200 and $39,800, respectively.
Pension Plans
As of
December 31, 2006, the Company adopted SFAS No. 158, Employers Accounting for Defined Benefit Pension and Other Postretirement Plans. This statement requires the recognition of the overfunded or underfunded status of
defined benefit pension and postretirement plans as an asset or liability in its statement of financial position and to recognize changes in that funded status in the year in which the changes occur through other comprehensive income. The statement
also changes financial reporting by requiring an employer to measure the funded status of a plan as of the date of its year-end statement of financial position. The Companys policy is to
12
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
fund U.S. pension plans at amounts not less than the minimum requirements of the Employee Retirement Income Security Act of 1974 and generally for
obligations under its foreign plans to deposit funds with trustees under insurance policies.
In 2002, the Board of Directors authorized a
plan to freeze the Companys pension plan in accordance with ERISA rules and regulations so that new employees, hired after July 31, 2002, will not be eligible to participate in the pension plan and further benefits will no longer accrue
for existing participants. The freezing of the pension plan had the effect of vesting all existing participants in their pension benefits in the plan.
Comprehensive Income (Loss)
Comprehensive income (loss) is defined as change in equity of a business enterprise
during a period from transactions and other events and circumstances from non-owner sources, including foreign currency translation adjustments, changes in the value of derivative contracts and pension benefits adjustments, including recognition of
actuarial losses. The Company presents comprehensive income (loss) in its consolidated statements of operations and comprehensive income and of stockholders equity.
Accumulated Comprehensive Loss
The components of accumulated other comprehensive loss
included in shareholders equity are as follows:
|
|
|
|
|
|
|
|
|
|
|
June 30,
2008
|
|
|
December 31,
2007
|
|
|
|
(in thousands)
|
|
Cumulative Translation Adjustments, net of tax benefit of $13 as of June 30, 2008 and December 31, 2007
|
|
$
|
(25
|
)
|
|
$
|
(25
|
)
|
Pension Benefits Adjustments, net of tax benefit of $3,245 as of June 30, 2008 and $3,377 as of December 31, 2007
|
|
|
(6,298
|
)
|
|
|
(6,553
|
)
|
Fair Value of Interest Rate Swap, net of tax benefit of $146 as of June 30, 2008 and $228 as of December 31, 2007
|
|
|
(282
|
)
|
|
|
(442
|
)
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Loss
|
|
$
|
(6,605
|
)
|
|
$
|
(7,020
|
)
|
|
|
|
|
|
|
|
|
|
Foreign Currency Translation
The Companys Mexican operations use the local currency as the functional currency. Assets and liabilities of those operations are translated into
U.S. dollars using period-end exchange rates; income and expenses are translated using the average exchange rates for the reporting period. Translation adjustments are deferred in accumulated other comprehensive income (loss), a separate component
of stockholders equity.
Concentrations of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and trade accounts receivable. The Companys customer base generally remains consistent from
year to year. The Company performs ongoing credit evaluations of its customers and generally does not require material collateral. The Company maintains reserves for potential credit losses and such losses have historically been within
managements expectations.
13
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
At June 30, 2008 and December 31, 2007, the Company had cash deposits concentrated primarily in one major bank. In addition, the Company had
certificates of deposit and commercial quality grade investments A2P2 rated or better with companies and financial institutions. The Company believes that credit risk in such investments is minimal.
Earnings per Share
Basic earnings per common
share (EPS) were computed by dividing net earnings by the weighted average number of common shares outstanding during the reporting period. Diluted EPS reflects the dilution that could occur if securities or contracts to issue common stock were
exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the Company. Diluted earnings per common share was computed by dividing net earnings by the sum of the weighted average number
of common shares outstanding plus the number of additional common shares that would have been outstanding if the dilutive potential common shares (in this case, exercise of the Companys employee stock options) had been issued during each
period as discussed in Note 10.
Purchase and Retirement of Common Stock
The Company accounts for the retirement of treasury shares under the par value method. Under this method, the excess of the cost of treasury stock over
its par value is charged to retained earnings.
Recently Issued Accounting Standards
In September 2006, the FASB issued Statement of Financial Accounting Standards (SFAS) No. 157, Fair Value Measurements (SFAS
No. 157). SFAS No. 157 establishes a common definition for fair value, establishes a framework for measuring fair value, and expands disclosure about such fair value measurements. SFAS No. 157 is effective for financial assets and
financial liabilities for fiscal years beginning after November 15, 2007. Issued in February 2008, FSP 157-1 Application of FASB Statement No. 157 to FASB Statement No. 13 and Other Accounting Pronouncements That Address Fair
Value Measurements for Purposes of Lease Classification or Measurement under Statement 13 removed leasing transactions accounted for under Statement 13 and related guidance from the scope of SFAS No. 157. FSP 157-2 Partial Deferral
of the Effective Date of Statement 157 (FSP 157-2), deferred the effective date of SFAS No. 157 for all nonfinancial assets and nonfinancial liabilities that are not recognized or disclosed at fair value in the financial statements on a
recurring basis (at least annually) to fiscal years beginning after November 15, 2008.
The implementation of SFAS No. 157 for
financial assets and financial liabilities, effective January 1, 2008, did not have a material impact on the Companys consolidated financial position and results of operations. The Company is currently assessing the impact of SFAS
No. 157 for nonfinancial assets and nonfinancial liabilities on its consolidated financial position and results of operations.
In
February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities Including an Amendment of FASB Statement No. 115 (SFAS No. 159). This statement permits
entities to choose to measure many financial assets and liabilities and certain other items at fair value. The objective is to improve financial reporting by providing entities with the opportunity to mitigate volatility in reported earnings caused
by measuring related assets and liabilities differently without having to apply complex hedge accounting provisions. Management decided not to apply the fair value option to any of the Companys existing financial assets and/or liabilities
effective January 1, 2008. As such, the statement had no impact on the Companys consolidated financial position and results of operations.
14
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
In December 2007, the FASB issued SFAS No. 141 (revised 2007), Business Combinations (SFAS 141(R)). SFAS 141(R) states that all business
combinations, whether full, partial, or step acquisitions, will result in all assets and liabilities of an acquired business being recorded at their fair values at the acquisition date. In subsequent periods, contingent liabilities will be measured
at the higher of their acquisition date fair value or the estimated amounts to be realized. SFAS 141(R) applies to all transactions or other events in which an entity obtains control of one or more businesses. This statement is effective as of the
beginning of an entitys first fiscal year beginning after December 15, 2008. The Company is currently evaluating the impact, if any, the adoption of SFAS No. 141(R) will have on its consolidated results of operations, financial
position and related disclosures.
In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated
Financial Statementamendments of ARB No. 51 (SFAS 160). SFAS 160 states that accounting and reporting for minority interests will be recharacterized as noncontrolling interests and classified as a component of equity. SFAS 160
applies to all entities that prepare consolidated financial statements, except not-for-profit organizations, but will affect only those entities that have an outstanding noncontrolling interest in one or more subsidiaries or that deconsolidate a
subsidiary. This statement is effective as of the beginning of an entitys first fiscal year beginning after December 15, 2008. The Company is currently evaluating the impact, if any, the adoption of SFAS No. 160 will have on its
consolidated results of operations, financial position and related disclosures.
In March 2008, the FASB issued SFAS No. 161,
Disclosures about Derivative Instruments and Hedging Activities (SFAS 161). SFAS 161 is a clarification of SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities which did not provide adequate
information about how derivative and hedging activities affect an entitys financial position, financial performance and cash flows. Accordingly, SFAS 161 requires enhanced disclosures about an entitys derivative and hedging activities
and thereby improves the transparency of financial reporting. This Statement is effective for financial statements issued for fiscal years and interim periods beginning after November 15, 2008. The Company is currently evaluating the impact, if
any, the adoption of SFAS 161 will have on its disclosures.
In May 2008, the FASB issued SFAS No. 162, The Hierarchy of
Generally Accepted Accounting Principles (SFAS No. 162). This statement identifies sources of accounting principles and the framework for selecting the principles to be used in the preparation of financial statements that are
presented in conformity with generally accepted accounting principles (GAAP) in the United States. SFAS No. 162 moves the hierarchy of GAAP sources for non-governmental entities from the auditing literature to the accounting
literature. This statement will become effective 60 days following approval by the Securities and Exchange Commission (SEC) of amendments made by the Public Company Accounting Oversight Board to AU Section 411, The Meaning of
Present Fairly in Conformity with Generally Accepted Accounting Principles. Any effect of applying SFAS No. 162 should be reported as a change in accounting principle. The Company does not expect this statement to have any impact on its
consolidated financial statements.
Stock-Based Compensation
The Company has a stock-based compensation plan, which is described in more detail in Note 11 to the consolidated financial statements of the Companys Form 10-K for the fiscal year ended December 31, 2007.
Net income (loss) for the three and six months ended June 30, 2008 and 2007 includes $160,000, $101,000, $214,000 and $164,000 ($106,000, $67,000, $141,000 and $108,000 after-tax), respectively, of share-based compensation costs which are
included in selling, general and administrative expenses in the condensed consolidated statement of operations and comprehensive income. As of June 30, 2008, there was $729,000 ($481,000 after-tax) of total unrecognized compensation costs
related to nonvested share-based compensation that is expected to be recognized over a weighted-average period of 1.8 years, of which $341,000 ($225,000 after-tax) of total share-based compensation is expected to be recognized during the remainder
of fiscal year 2008.
15
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
Note 2. Accounts Receivable
Accounts receivable as of
June 30, 2008 and December 31, 2007 are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
June 30,
2008
|
|
|
December 31,
2007
|
|
|
|
(in thousands)
|
|
Trade
|
|
$
|
19,796
|
|
|
$
|
14,767
|
|
Insurance
|
|
|
692
|
|
|
|
727
|
|
Employee
|
|
|
73
|
|
|
|
21
|
|
Stock option proceeds due from brokers
|
|
|
384
|
|
|
|
|
|
Income tax
|
|
|
362
|
|
|
|
583
|
|
Other
|
|
|
76
|
|
|
|
73
|
|
|
|
|
|
|
|
|
|
|
Total accounts receivable
|
|
|
21,383
|
|
|
|
16,171
|
|
Less: allowance for doubtful accounts
|
|
|
(144
|
)
|
|
|
(120
|
)
|
|
|
|
|
|
|
|
|
|
Receivables, net
|
|
$
|
21,239
|
|
|
$
|
16,051
|
|
|
|
|
|
|
|
|
|
|
Note 3. Inventory
The major classes of inventory as of June 30, 2008 and December 31, 2007 are summarized as follows:
|
|
|
|
|
|
|
|
|
June 30,
2008
|
|
December 31,
2007
|
|
|
(in thousands)
|
Fish meal
|
|
$
|
27,817
|
|
$
|
42,937
|
Fish oil
|
|
|
10,905
|
|
|
13,590
|
Fish solubles
|
|
|
854
|
|
|
1,461
|
Unallocated inventory cost pool (including off-season costs)
|
|
|
30,037
|
|
|
6,848
|
Other materials & supplies
|
|
|
7,126
|
|
|
6,016
|
|
|
|
|
|
|
|
Total inventory
|
|
$
|
76,739
|
|
$
|
70,852
|
|
|
|
|
|
|
|
Inventory at June 30, 2008 and December 31, 2007 is stated at the lower of cost or
market. The elements of unallocated inventory cost pool include plant and vessel related labor, utilities, rent, repairs and depreciation, to be allocated to inventories produced through the remainder of the 2008 fishing season.
Note 4. Other Assets
Other assets as of
June 30, 2008 and December 31, 2007 are summarized as follows:
|
|
|
|
|
|
|
|
|
June 30,
2008
|
|
December 31,
2007
|
|
|
(in thousands)
|
Fish nets, net of accumulated amortization of $3,067 and $2,008
|
|
$
|
1,667
|
|
$
|
1,093
|
Insurance receivable, net of allowance for doubtful accounts
|
|
|
1,311
|
|
|
1,082
|
Title XI loan origination fee
|
|
|
345
|
|
|
374
|
Other debt issuance costs
|
|
|
606
|
|
|
736
|
Deposits and other
|
|
|
60
|
|
|
59
|
|
|
|
|
|
|
|
Total other assets, net
|
|
$
|
3,989
|
|
$
|
3,344
|
|
|
|
|
|
|
|
16
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
Amortization expense for fishing nets amounted to approximately $251,000, $173,000, $501,000 and $371,000 for the three and six months ended June 30,
2008 and 2007, respectively.
The Company carries insurance for certain losses relating to its vessels and Jones Act liability for
employees aboard its vessels (collectively, Vessel Claims Insurance). The typical Vessel Claims Insurance policy contains an annual aggregate deductible (AAD) for which the Company remains responsible, while the insurance
carrier is responsible for all applicable amounts which exceed the AAD. It is the Companys policy to accrue current amounts due and record amounts paid out on each claim. Once payments exceed the AAD, the Company records an insurance
receivable for a given policy year, net of allowance for doubtful accounts. As of June 30, 2008 and December 31, 2007 the allowance for doubtful insurance receivable accounts was $2.0 million.
Note 5. Property and Equipment
Property and
equipment at June 30, 2008 and December 31, 2007 are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
June 30,
2008
|
|
|
December 31,
2007
|
|
|
|
(in thousands)
|
|
Land
|
|
$
|
7,690
|
|
|
$
|
7,690
|
|
Plant assets
|
|
|
102,880
|
|
|
|
101,171
|
|
Fishing vessels and marine equipment
|
|
|
95,609
|
|
|
|
95,193
|
|
Furniture and fixtures
|
|
|
5,079
|
|
|
|
5,049
|
|
Construction in progress
|
|
|
14,285
|
|
|
|
4,166
|
|
|
|
|
|
|
|
|
|
|
Total property and equipment
|
|
|
225,543
|
|
|
|
213,269
|
|
Less: accumulated depreciation and impairment
|
|
|
(121,071
|
)
|
|
|
(116,610
|
)
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net
|
|
$
|
104,472
|
|
|
$
|
96,659
|
|
|
|
|
|
|
|
|
|
|
Depreciation expense for the three and six months ended June 30, 2008 and 2007 was $2.9
million, $3.1 million, $5.8 million and $6.3 million, respectively.
Note 6. Notes Payable and Long-Term Debt
At June 30, 2008 and December 31, 2007, the Companys long-term debt consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
June 30,
2008
|
|
|
December 31,
2007
|
|
|
|
(in thousands)
|
|
U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant
assets:
|
|
|
|
|
|
|
|
|
Amounts due in installments through 2016, interest from 6.49% to 7.6%
|
|
$
|
29,444
|
|
|
$
|
30,858
|
|
Amounts due in installments through 2014, interest at Eurodollar rates plus 0.45% (3.15% and 5.68% at June 30, 2008 and December 31,
2007, respectively)
|
|
|
256
|
|
|
|
276
|
|
Bank of America term loan, quarterly principal payments as defined, interest payable quarterly based on LIBOR plus an applicable rate (4.80%
and 7.45% as of June 30, 2008 and December 31, 2007, respectively) maturing March 2012
|
|
|
32,375
|
|
|
|
34,125
|
|
|
|
|
|
|
|
|
|
|
Total debt
|
|
|
62,075
|
|
|
|
65,259
|
|
Less current maturities
|
|
|
(6,983
|
)
|
|
|
(6,283
|
)
|
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
$
|
55,092
|
|
|
$
|
58,976
|
|
|
|
|
|
|
|
|
|
|
17
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
The Title XI loans are secured by liens on certain of the Companys fishing vessels and mortgages on the Companys Reedville, Virginia and
Abbeville, Louisiana plants. Loans are now available under similar terms pursuant to the Title XI program without intervening lenders.
In
September 2004, pursuant to the Title XI program, the United States Department of Commerce Fisheries Finance Program (the FFP) approved the Companys financing application in an amount not to exceed $14 million (the Approval
Letter). Borrowings under the Approval Letter are to be used to finance and/or refinance approximately 73% of the actual depreciable cost of the Companys future fishing vessel refurbishments and capital expenditures relating to
shore-side fishing assets for a term not to exceed 15 years from inception at interest rates determined by the U.S. Treasury. Final approval for all such future projects requires individual approval through the Secretary of Commerce, National
Oceanic and Atmospheric Administration, and National Marine Fisheries Service (National Marine Fisheries Service). Borrowings under the FFP are required to be evidenced by security agreements, undertakings, and other documents deemed in
the sole discretion of the National Marine Fisheries Service as necessary to accomplish the intent and purpose of the Approval Letter. The Company is required to comply with customary National Marine Fisheries Service covenants as well as certain
special covenants. In December 2004, the Company submitted a $4.9 million financing request against the $14 million approval, and subsequently amended that request to include the entire $14 million. The Company closed on the $14 million FFP loan on
October 17, 2005.
On December 1, 2005, pursuant to the Title XI program, the FFP approved a second financing application made by
the Company in the amount of $16.4 million (the Second Approval Letter). In May 2006, the Company submitted a $6.3 million financing request under the Second Approval Letter. The Company closed on the $6.3 million FFP loan in the first
quarter of 2007. As of June 30, 2008, the Company was in compliance with all of the covenants contained therein.
On March 26,
2007 (the Closing Date), the Company entered into a Credit Agreement (the Credit Agreement) with Bank of America, N.A., as administrative agent, lender, swing line lender and letter of credit issuer, Regions Bank, Compass
Bank and Farm Credit Bank of Texas (collectively, the Lenders). The Credit Agreement provides the Company with a $55 million senior credit facility (the Senior Credit Facility) consisting of (i) a 5-year revolving credit
facility (the Revolving Credit Facility) of up to $20 million, including a $7.5 million sub-limit for the issuance of standby letters of credit and a $2.5 million sub-limit for swing line loans and (ii) a 5-year term loan (the
Term Loan) of $35 million. The Senior Credit Facility replaced the Companys prior credit facility, under which, as of the Closing Date, $28.7 million in principal was outstanding under a term loan and $6.5 million in principal was
outstanding under revolving loans, and approximately $3.3 million in letters of credit were issued, primarily in support of workers compensation insurance programs. On the Closing Date, the Company drew down $35 million under the Term Loan and
approximately $2.0 million under the Revolving Credit Facility, and had approximately $3.1 million issued in standby letters of credit, primarily in support of workers compensation insurance programs. The Senior Credit Facility is secured by a
first priority lien on all of the Companys assets, other than vessels, real estate and other assets pledged to secure loans made to the Company under the FFP.
During the six month period ended June 30, 2007, as a result of the above mentioned refinancing, the Company expensed approximately $2.2 million in deferred debt issuance costs and $0.8 million as a prepayment
penalty related to the prior credit facility.
As of June 30, 2008, the Company had $32.4 million outstanding under the Term Loan and
$2.8 million in letters of credit issued primarily in support of workers compensation insurance programs. As of June 30, 2008, the Company had $13.1 million available under the Revolving Credit Facility and the Company was in compliance
with all of the covenants under the Senior Credit Facility. The Company has no off-balance sheet arrangements other than normal operating leases and standby letters of credit.
18
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
Note 7. Capital Lease Obligation
On May 29,
2008, the Company entered into a capital lease agreement to lease a barge for a period of 5 years. Following is a summary of future minimum payments under the capitalized lease agreement (in thousands):
|
|
|
|
|
2008
|
|
$
|
129
|
|
2009
|
|
|
263
|
|
2010
|
|
|
276
|
|
2011
|
|
|
290
|
|
2012
|
|
|
305
|
|
2013
|
|
|
128
|
|
|
|
|
|
|
Total minimum lease payments
|
|
|
1,391
|
|
Less amount representing interest
|
|
|
(364
|
)
|
|
|
|
|
|
Present value of minimum payments
|
|
|
1,027
|
|
Less current portion of capital lease obligation
|
|
|
(137
|
)
|
|
|
|
|
|
Long-term capital lease obligation
|
|
$
|
890
|
|
|
|
|
|
|
As of June 30, 2008, assets recorded under capital lease obligations are included in
Property, Plant and Equipment, net as follows (in thousands):
|
|
|
|
|
Fishing vessels and marine equipment, at cost
|
|
$
|
1,038
|
|
Less accumulated depreciation
|
|
|
(17
|
)
|
|
|
|
|
|
Property, plant and equipment, net
|
|
$
|
1,021
|
|
|
|
|
|
|
Subsequent to June 30, 2008, the Company entered into a second capital lease agreement to
lease a barge for a period of 5 years with terms similar the above lease. The second lease will be reflected in the Companys third quarter financial statements.
Note 8. Accrued Liabilities
Accrued liabilities as of June 30, 2008 and December 31, 2007
are summarized as follows:
|
|
|
|
|
|
|
|
|
June 30,
2008
|
|
December 31,
2007
|
|
|
(in thousands)
|
Salary and benefits
|
|
$
|
6,768
|
|
$
|
3,959
|
Insurance
|
|
|
4,737
|
|
|
4,611
|
Taxes, other than income tax
|
|
|
901
|
|
|
33
|
Trade creditors
|
|
|
8,218
|
|
|
5,106
|
Fair market value of interest rate swap, current portion
|
|
|
398
|
|
|
211
|
FIN 48 liability
|
|
|
159
|
|
|
|
Income tax payable
|
|
|
346
|
|
|
|
Other
|
|
|
464
|
|
|
1,147
|
|
|
|
|
|
|
|
Total accrued liabilities
|
|
$
|
21,991
|
|
$
|
15,067
|
|
|
|
|
|
|
|
19
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
Note 9. Commitments and Contingencies
Litigation
The Company is defending various claims and litigation arising from its operations which arise in the ordinary course of the Companys business.
In the opinion of management, and based on advice of legal counsel, it is believed that any existing litigation involving the Company will not materially affect its financial condition, cash flows or future results of operations.
Insurance
The Company carries insurance with
coverages and coverage limits that it believes to be appropriate for the business. Although there can be no assurance that such insurance is sufficient to protect the Company against all contingencies, management believes that its insurance
protection is reasonable in view of the nature and scope of the Companys operations. Should the Companys insurers become insolvent, the Company is responsible for payment of all outstanding claims associated with the insurers
policies.
Environmental Matters
The
Company is subject to various possible claims and lawsuits regarding environmental matters. Management believes that costs, if any, related to these matters will not have a material adverse effect on the results of operations, cash flows or
financial position of the Company.
Indemnification
The Companys Articles of Incorporation and By-Laws limit the liability of the Companys officers and directors to the fullest extent permitted by Nevada law. Nevada provides that directors of Nevada
corporations may be relieved of monetary liabilities for breach of their fiduciary duties as directors, except under certain circumstances, including (i) acts or omissions which involve intentional misconduct, fraud or a knowing violation of
law or (ii) the willful or grossly negligent payment of unlawful distributions.
The Companys Articles of Incorporation and
By-Laws generally require the Company to indemnify its directors and officers to the fullest extent permitted by Nevada law. The Companys Articles of Incorporation and By-Laws also require the Company to advance expenses to its directors and
its officers to the fullest extent permitted by Nevada law upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it should be ultimately determined that they are not entitled to indemnification by the
Company. The Company also has entered into indemnification agreements with all of its directors and certain of its officers which provides for the indemnification and advancement of expenses by the Company. The Company also maintains director and
officer liability insurance with respect to liabilities arising out of certain matters, including matters arising under the securities laws. This insurance is subject to limitations, conditions and deductibles set forth in the respective insurance
policy.
Note 10. Reconciliation of Basic and Diluted Per Share Data (in thousands except per share data)
|
|
|
|
|
|
|
|
|
|
|
Earnings
(Numerator)
|
|
Shares
(Denominator)
|
|
Per Share
Data
|
Three Months Ended June 30, 2008
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
6,710
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share:
|
|
|
|
|
|
|
|
|
Earnings available to common shareholders
|
|
$
|
6,710
|
|
18,328
|
|
$
|
0.37
|
|
|
|
|
|
|
|
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
Stock options assumed exercised
|
|
|
|
|
375
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per common share:
|
|
|
|
|
|
|
|
|
Earnings available to common shareholders plus stock options assumed exercised
|
|
$
|
6,710
|
|
18,703
|
|
$
|
0.36
|
|
|
|
|
|
|
|
|
|
20
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
|
|
|
|
|
|
|
|
|
|
|
Earnings
(Numerator)
|
|
Shares
(Denominator)
|
|
Per Share
Data
|
Three Months Ended June 30, 2007
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
2,515
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share:
|
|
|
|
|
|
|
|
|
Earnings available to common shareholders
|
|
$
|
2,515
|
|
16,598
|
|
$
|
0.15
|
|
|
|
|
|
|
|
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
Stock options assumed exercised
|
|
|
|
|
753
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per common share:
|
|
|
|
|
|
|
|
|
Earnings available to common shareholders plus stock options assumed exercised
|
|
$
|
2,515
|
|
17,351
|
|
$
|
0.14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings
(Numerator)
|
|
Shares
(Denominator)
|
|
Per Share
Data
|
Six Months Ended June 30, 2008
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
8,622
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share:
|
|
|
|
|
|
|
|
|
Earnings available to common shareholders
|
|
$
|
8,622
|
|
17,925
|
|
$
|
0.48
|
|
|
|
|
|
|
|
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
Stock options assumed exercised
|
|
|
|
|
433
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per common share:
|
|
|
|
|
|
|
|
|
Earnings available to common shareholders plus stock options assumed exercised
|
|
$
|
8,622
|
|
18,358
|
|
$
|
0.47
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings
(Numerator)
|
|
Shares
(Denominator)
|
|
Per Share
Data
|
Six Months Ended June 30, 2007
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
203
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share:
|
|
|
|
|
|
|
|
|
Earnings available to common shareholders
|
|
$
|
203
|
|
16,465
|
|
$
|
0.01
|
|
|
|
|
|
|
|
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
Stock options assumed exercised
|
|
|
|
|
815
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per common share:
|
|
|
|
|
|
|
|
|
Earnings available to common shareholders plus stock options assumed exercised
|
|
$
|
203
|
|
17,280
|
|
$
|
0.01
|
|
|
|
|
|
|
|
|
|
21
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
Options to purchase 123,400 and 1,192,600 shares of common stock at exercise prices ranging from $13.41 to $17.25 per share and $12.38 to $17.25 per share
were outstanding during the three and six months ended June 30, 2008, respectively, but were not included in the computation of diluted earnings per share because the exercise prices of the options were greater than the average market price of
the shares during that period.
Options to purchase 2,575,000 and 2,664,200 shares of common stock at exercise prices ranging from $7.25 to
$17.25 per share were outstanding during the three and six months ended June 30, 2007, respectively, but were not included in the computation of diluted earnings per share because the exercise prices of the options were greater than the average
market price of the shares during that period.
Note 11. Components of Net Periodic Benefit Cost
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30,
|
|
|
Six Months Ended
June 30,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
Service cost
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Interest cost
|
|
|
376
|
|
|
|
376
|
|
|
|
752
|
|
|
|
752
|
|
Expected return on plan assets
|
|
|
(401
|
)
|
|
|
(405
|
)
|
|
|
(802
|
)
|
|
|
(810
|
)
|
Amortization of prior service costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of net loss
|
|
|
194
|
|
|
|
204
|
|
|
|
388
|
|
|
|
408
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic pension cost
|
|
$
|
169
|
|
|
$
|
175
|
|
|
$
|
338
|
|
|
$
|
350
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the six months ended June 30, 2008, the Company made approximately $0.9 million in
contributions to the Companys pension plan. The Company expects to make contributions of $0.5 million to the pension plan during the remainder of 2008. For the six months ended June 30, 2007, the Company had made $1.0 million in
contributions to the pension plan.
Note 12. Hurricane Losses and Insurance Recoveries
On August 29, 2005, the Companys Moss Point, Mississippi fish processing facility and adjacent shipyard were severely damaged by Hurricane
Katrina. On September 24, 2005, the Companys Cameron, Louisiana and the Abbeville, Louisiana fish processing facilities were also severely damaged by Hurricane Rita. Each of these facilities was non-operational immediately after these
weather related events. For the three and six month periods ended June 30, 2008 and 2007, no hurricane losses or insurance recoveries were recognized in the Companys statement of operations. See Note 12 in the Companys Annual Report
on Form 10-K for the year ended December 31, 2007 for additional information.
Note 13. Fair Value Disclosures
Effective January 1, 2008, the Company adopted SFAS 157 as discussed in Note 1, which, among other things, requires enhanced disclosures about assets
and liabilities carried at fair value.
The standard defines fair value, provides a consistent framework for measuring fair value under
accounting principles generally accepted in the United States and expands fair value financial statement disclosure requirements. SFAS 157 does not require any new fair value measurements. It only applies to accounting pronouncements that already
require or permit fair value measures, except for standards that relate to share-based payments (SFAS 123R Share Based Payment) and to lease accounting (SFAS 13).
22
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
SFAS 157s valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent
sources, while unobservable inputs reflect our market assumptions. The Standard classifies these inputs into the following hierarchy:
Level 1 Inputs Quoted prices for identical instruments in active markets.
Level 2 Inputs Quoted prices for similar
instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.
Level 3 Inputs Instruments with primarily unobservable value drivers.
The following table sets forth by level within the fair value hierarchy the Companys financial liabilities that were accounted for at fair value on
a recurring basis as of June 30, 2008. As required by SFAS 157, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Companys
assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2008
|
|
|
|
Fair Value Measurements Using
|
|
|
Liabilities at
Fair Value
|
|
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
|
Liabilities (in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swap liability
|
|
$
|
|
|
$
|
|
|
$
|
(429
|
)
|
|
$
|
(429
|
)
|
The determination of the fair values above incorporates various factors required under SFAS 157.
These factors include not only the credit standing of the counterparties involved and the impact of credit enhancements (such as cash deposits, letters of credit and priority interests), but also the impact of the Companys nonperformance risk
on its liabilities.
The fair value of the interest rate swap liability is determined using an income valuation model based on the present
value of expected future cash flows as determined by comparing the Companys rate to the Euro-dollar futures curve. This model includes inputs or significant value drivers which might not be observable in or corroborated by the market. When
such inputs have a significant impact on the measurement of fair value, the instrument is categorized in level 3.
The fair value of the
natural gas call options was derived from the underlying market price, strike price, volatility, interest rate, and time to expiration. The interest rate and underlying market price are based upon a Eurodollar curve and NYMEX natural gas curve
published by the CME and NYMEX, respectively. The interest rates utilized are extrapolated through a model and volatility is based on historical 20-day volatility as calculated using the NYMEX underlying prices. This model includes inputs or
significant value drivers which might not be observable in or corroborated by the market. When such inputs have a significant impact on the measurement of fair value, the instrument is categorized in level 3.
23
OMEGA PROTEIN CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
The following table provides a reconciliation of all assets and (liabilities) measured at fair value on a recurring basis which use level three or
significant unobservable inputs or significant value drivers for the three and six months ended June 30, 2008 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Fair value Measurements
Using Significant
Unobservable Inputs
(Level 3 Inputs)
|
|
|
|
Three Months
Ended
June 30, 2008
|
|
|
Six Months
Ended
June 30,
2008
|
|
Beginning Balance
|
|
$
|
(1,415
|
)
|
|
$
|
(670
|
)
|
Net gain reclassified into earnings related to natural gas call options
|
|
|
59
|
|
|
|
29
|
|
Net change associated with current period natural gas call options activity
|
|
|
(29
|
)
|
|
|
(29
|
)
|
Net loss reclassified into earnings related to swap transactions
|
|
|
(138
|
)
|
|
|
(129
|
)
|
Net change associated with current period swap transactions
|
|
|
1,094
|
|
|
|
370
|
|
|
|
|
|
|
|
|
|
|
Ending Balance
|
|
$
|
(429
|
)
|
|
$
|
(429
|
)
|
|
|
|
|
|
|
|
|
|
24
OMEGA PROTEIN CORPORATION
Item 2.
|
Managements Discussion and Analysis of Financial Condition and Results of Operations
|
Forward-looking statements in this Form 10-Q, future filings by the Company with the Securities and Exchange Commission (the Commission),
the Companys press releases and oral statements by authorized officers of the Company are intended to be subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that all
forward-looking statements involve risks and uncertainty, including without limitation, the risks set forth under the caption Risk Factors and Significant Factors that May Affect Forward-Looking Statements appearing in Item 1A.
Risk Factors. The Company believes that forward-looking statements made by it are based on reasonable expectations; however, no assurances can be given that actual results will not differ materially from those contained in such
forward-looking statements. Forward-looking statements include statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include the words estimate, project,
anticipate, expect, predict, assume, believe, could, would, hope, may, and similar expressions.
General
Omega Protein Corporation is the
largest processor, marketer and distributor of fish meal and fish oil products in the United States. As used herein, the term Omega or the Company refers to Omega Protein Corporation or to Omega Protein Corporation and its
consolidated subsidiaries, as applicable. The Companys principal executive offices are located at 2105 City West Boulevard, Suite 500, Houston, Texas 77042-2838 (Telephone: (713) 623-0060).
The Company produces and sells a variety of protein and oil products derived from menhaden, a species of wild herring-like fish found along the Gulf of
Mexico and Atlantic coasts. The fish are not genetically modified or genetically enhanced. The Company processes several grades of fish meal, as well as fish oil and fish solubles. The Companys fish meal products are primarily used as a
protein ingredient in animal feed for swine, cattle, aquaculture and household pets. Fish oil is utilized for animal and aquaculture feeds, industrial applications, additives to human food products and as dietary supplements. The Companys fish
solubles are sold primarily to livestock feed manufacturers, aquaculture feed manufacturers and for use as an organic fertilizer.
The
Company operates four menhaden processing plants: two in Louisiana, one in Mississippi and one in Virginia. The Company also operates a Health and Science Center in Reedville, Virginia, which provides 100-metric tons per day fish oil processing
capacity for the Companys food, industrial and feed grade oils. In January 2007, the Company opened its new technical center in Houston, Texas The OmegaPure Technology and Innovation Center. The technical center has food science
application labs as well as analytical, sensory, lipids research and pilot plant capabilities.
In late 2005, the Company sustained damage
to property, plant and equipment at each of its Gulf of Mexico facilities due to Hurricanes Katrina and Rita. The Moss Point and Abbeville facilities were fully operational at the start of the 2006 season and the Cameron facility became fully
operational towards the end of the 2006 season. Total processing capacity, post-hurricanes, was reduced from 950,000 tons to 850,000 tons. The decrease in annual processing capacity will have no effect on the Companys ability to process in the
future because the Company has historically operated at levels substantially below maximum capacity.
All of the Companys products
contain healthy long-chain Omega-3 fatty acids. Omega-3 fatty acids are commonly referred to as essential fatty acids because the human and animal bodies do not produce them. Instead, essential fatty acids must be obtained from outside
sources, such as food or special supplements. Long-chain Omega-3s are also commonly referred to as a good fat for their health benefits, as opposed to the bad fats that create or aggravate health conditions through long-term
consumption. Scientific research suggests that long-chain Omega-3s as part of a balanced diet may provide significant benefits for health issues such as cardiovascular disease, inflammatory conditions and other ailments.
25
OMEGA PROTEIN CORPORATION
Under its production process, the Company produces OmegaPure
®
, a taste-free, odorless refined fish oil which is the only marine source of long-chain Omega-3s directly affirmed by the U.S. Food and Drug Administration (FDA) as a food
ingredient that is Generally Recognized as Safe (GRAS). See Company OverviewProducts Refined Fish Oil Food Grade Oils.
The Company operates through two primary subsidiaries: Omega Protein, Inc. and Omega Shipyard, Inc. Omega Protein, Inc. is the Companys principal operating subsidiary for its menhaden processing business and is
the successor to a business conducted since 1913. Omega Shipyard, Inc. owns a drydock facility in Moss Point, Mississippi, which is used to provide shoreside maintenance for the Companys fishing fleet and, subject to outside demand and excess
capacity, occasionally for third-party vessels. Revenues from shipyard work for third-party vessels for the six months ended June 30, 2008 and 2007 were not material. The Company also has a number of other immaterial direct and indirect
subsidiaries.
Until April 1998, the Company, including its predecessors, was a wholly-owned subsidiary of Zapata Corporation
(Zapata). In April 1998, the Company completed an initial public offering of its common stock. Immediately following the initial public offering, Zapata owned approximately 60% of the Companys outstanding common stock. On
December 8, 2005, Zapata announced that its Board of Directors had authorized Zapatas management to seek a buyer for its then 58% equity ownership interest in the Company.
On November 28, 2006, the Company purchased 9,268,292 shares of the Companys common stock from Zapata at a purchase price of $5.125 per share,
or an aggregate purchase price of $47.5 million. The Company financed the purchase of the shares from Zapata with a senior secured financing facility from Ableco Finance LLC, an affiliate of Cerberus Capital Management, L.P. Concurrent with the
purchase, Zapatas two representatives, Avram A. Glazer and Leonard DiSalvo, resigned from Omegas Board of Directors. Immediately following the purchase by the Company, Zapata owned approximately 33% of the Companys outstanding
common stock. For a more detailed description of the terms of the purchase by the Company, see the Companys Current Reports on Form 8-K filed with the SEC on September 12, 2006 and December 1, 2006.
On December 4, 2006, Zapata sold the remaining 5,232,708 shares of the Companys common stock held by Zapata to certain purchasers in a private
transaction. As a result of the sale by Zapata, Zapata no longer owns any shares of the Companys common stock. For a more detailed description of the terms of the sale by Zapata, see the Companys Current Report on Form 8-K filed with the
SEC on December 5, 2006.
Company Overview
Business
. Omega is the largest U.S. producer of protein-rich meal and oil derived from marine sources. The Companys products are produced from menhaden (a herring-like fish found in commercial
quantities), and includes regular grade and value-added specialty fish meals, crude and refined fish oils and fish solubles.
Fishing
. During the second quarter of 2008, the Company owned a fleet of 58 fishing vessels and 32 spotter aircraft for use in its fishing operations and also leased additional aircraft where necessary to facilitate operations.
During the 2008 fishing season in the Gulf of Mexico, which runs from mid-April through October, the Company is operating 31 fishing and carry vessels and 30 spotter aircraft. The fishing area in the Gulf is generally located along the Gulf Coast,
with a concentration off the Louisiana and Mississippi coasts. The fishing season along the Atlantic coast begins in early May and usually extends into December. During the 2008 season, the Company is operating 10 fishing vessels and 8 spotter
aircraft along the Mid-Atlantic coast, concentrated primarily in and
26
OMEGA PROTEIN CORPORATION
around Virginia and North Carolina. The remaining fleet of fishing vessels and spotter aircraft are not routinely operated during the fishing season and are
back-up to the active fleet, used for other transportation purposes, inactive or in the process of refurbishment in the Companys shipyard.
Menhaden usually school in large, tight clusters and are commonly found in warm, shallow waters. Spotter aircraft locate the schools and direct the fishing vessels to them. The principal fishing vessels transport two 40-foot purse boats,
each carrying several fishermen and one end of a 1,500-foot net. The purse boats encircle the school and capture the fish in the net. The fish are then pumped from the net into refrigerated holds of the fishing vessel or onto a carry vessel, and
then are unloaded at the Companys processing plants. Carry vessels do not engage in active fishing but instead carry fish from the Companys offshore fishing vessels to its plants. Utilization of carry vessels increases the
amount of time that certain of the Companys fishing vessels remain offshore fishing productive waters and therefore increases the Companys fish catch per vessel employed. The carry vessels have reduced crews and crew expenses and incur
less maintenance cost than the actual fishing vessels.
The Companys principal raw material is menhaden, a species of fish that
inhabits coastal and inland tidal waters in the United States. Certain state agencies, as well as interstate compacts, impose resource depletion restrictions on menhaden pursuant to fisheries management legislation or regulations and may impose
additional legislation or regulations in the future. For example, in February 2007, the Commonwealth of Virginia established an annual cap for a five year period beginning in 2006 on the Companys menhaden landings from the Chesapeake Bay in an
amount equal to the Companys average annual landings over a five year period from 2001 to 2005 (approximately 109,020 metric tons). The Virginia restrictions also allow the Company a credit whereby any under-harvest in a particular year below
the 109,020 metric ton cap would be added to increase the cap for the following year, up to a maximum of 122,740 metric tons per year. In April 2008, the State of Texas enacted regulations which limited the annual menhaden catch to a five year
average of 31.5 million pounds. The regulation also allows a 10% underage or overage in each year which is credited or deducted, as applicable, to the total allowable catch in the following year. This regulation is expected to be effective
commencing with the 2009 fishing season. In addition, two bills have been introduced in the U.S. House of Representatives, which the Company believes have very little chance of passage, but which would ban menhaden fishing in Atlantic waters. To
date, the Company has not experienced any material adverse impact on its fish catch or results of operations as a result of these restrictions.
Meal and Oil Processing Plants
. The Company operates four meal and oil processing plants, two in Louisiana, one in Mississippi and one in Virginia, where the menhaden are processed into three general product types: fish meal, fish
oil and fish solubles. The Companys processing plants are located in coastal areas near the Companys fishing fleet. Annual volume processed varies depending upon menhaden catch. Each plant maintains a dedicated dock to unload fish, fish
processing equipment and storage facilities. The fish are unloaded from the fishing vessels into storage boxes and then conveyed into steam cookers. The fish are then passed through presses to remove most of the oil and water. The solid portions of
the fish are dried and ground into fish meal. The liquid that is produced in the cooking and pressing operations contains oil, water, dissolved protein and some fish solids. This liquid is decanted to remove the solids and is put through a
centrifugal oil and water separation process. The separated fish oil is a finished product called crude oil. The separated water and protein mixture is further processed through evaporators to recover the soluble protein, which can be sold as a
finished product or added to the solid portions of the fish for processing into fish meal.
Shipyard.
The Company owns a 49.4 acre
shipyard facility in Moss Point, Mississippi which includes two dry docks, each with a capacity of 1,300 tons. The shipyard is used for routine maintenance and vessel refurbishment on the Companys fishing vessels and occasionally for shoreside
maintenance services to third-party vessels if excess capacity exists.
27
OMEGA PROTEIN CORPORATION
Health and Science Center
. In October 2004, the Company completed construction and commenced operation of a Health
and Science Center that provides 100-metric tons per day fish oil processing capacity. The center is located adjacent to the Companys Reedville, Virginia processing plant. The food-grade facility includes state-of-the-art processing equipment
and controls that allows the Company to refine, bleach, fractionate and deodorize its menhaden fish oil and has more than tripled the Companys previous refined fish oil production capacity for food, industrial and feed grade oils. The facility
also provides the Company with automated packaging and on-site frozen storage capacity and has a lipids analytical laboratory to enhance the development of Omega-3 oils and food products.
OmegaPure Technology and Innovation Center.
In January 2007, the Company opened its new
OmegaPure Technology and Innovation Center located in Houston, Texas to further develop its OmegaPure
®
food grade Omega-3 product line. The new facility has food science application labs,
as well as analytical, sensory and pilot plant capabilities. The new facility also has a lipids research lab where the Company plans to continue to develop new Omega-3 products that have improved functionality and technical characteristics.
Hurricane Damages
. In August 2005, the Companys Moss Point, Mississippi fish processing facility and adjacent shipyard were
severely damaged by Hurricane Katrina. In September 2005, the Companys Cameron, Louisiana and Abbeville, Louisiana fish processing facilities were also severely damaged by Hurricane Rita. Each of these facilities was non-operational
immediately after these weather events. The Moss Point, Abbeville and Cameron facilities accounted for approximately 16%, 31% and 22%, respectively, of the Companys full year 2004 production tonnage, so as an immediate result of the two
hurricanes, approximately 70% of the Companys operating capacity was impaired and the Companys business, results of operations and financial condition were materially adversely affected.
Operations at the Moss Point and Abbeville fish processing facilities and the shipyard were re-established in mid-October 2005, but at reduced processing
capabilities. These two facilities were returned to full operational status prior to the beginning of the Gulf fishing season in April 2006. Operations at the Cameron fish processing facility were re-established in June 2006, but at reduced
processing capabilities. The Cameron plant became fully operational in September 2006.
The Company maintains insurance coverage for a
variety of these damages, most notably property, inventory and vessel insurance. The nature and extent of the insurance coverage varies by line of policy and the Company has recorded insurance recoveries as an account receivable based on the
preliminary discussions with insurers and adjusters.
The direct impact of the two hurricanes upon the Company was a loss of physical
inventories and physical damage to the plants. As of June 30, 2008, the Company estimated its cumulative hurricane damages at approximately $29.3 million, of which $12.0 million was recorded as a receivable under insurance policies as of
September 30, 2005 and was fully received as of September 30, 2007. In addition to the $12.0 million receivable recorded as of September 30, 2005, the Company realized additional insurance recoveries of $5.2 million and $5.5 million
during the third and fourth quarters of 2007, respectively. The Company has recognized a cumulative $6.6 million net loss through June 30, 2008 due to estimated damages in excess of recognized insurance recoveries.
In order to facilitate the insurance recovery process, on July 28, 2006, the Company filed a lawsuit against its property insurance carriers,
Lexington Insurance Company and RSUI Indemnity Company, in the U.S. District Court for the Western District of Louisiana, alleging breach of contract and bad faith based on the insurance carriers failure to pay amounts due to the Company under
its property insurance policies for damages sustained from Hurricanes Katrina and Rita in the third quarter of 2005. The Company settled its lawsuit with its primary property insurance carrier, Lexington Insurance Company, for a total of $19.8
million during the third quarter of
28
OMEGA PROTEIN CORPORATION
2007. Of the $19.8 million, $12.0 million was previously recorded as a receivable and was fully received as of September 30, 2007, $3.3 million was paid
to outside legal counsel in connection with the settlement and $4.5 million was recognized during the third quarter of 2007 as insurance recoveries relating to natural disaster and was received as of December 31, 2007. In addition, the Company
settled its lawsuit with its secondary property insurance carrier, RSUI Indemnity Company, for a total of $9.2 million during the fourth quarter of 2007. Of the $9.2 million, $0.7 million was advanced during the third quarter of 2007 and recognized
as insurance recoveries relating to natural disaster, $3.0 million was paid to outside legal counsel in connection with the settlement during the fourth quarter of 2007 and $5.5 million was recognized and received during the fourth quarter of 2007
as insurance recoveries relating to natural disaster. The Company still has a pending lawsuit against its insurance broker alleging negligent procurement, negligent misrepresentation, breach of contract and violations of Texas Insurance and Consumer
laws. See the Companys Annual Report on Form 10-K for the fiscal year ended December 31, 2007, Part I, Item 3. Legal Proceedings for additional information.
As of December 31, 2005, the Companys four active processing plants, assuming that no hurricane damages had occurred, would have had an
aggregate annual capacity to process approximately 950,000 tons of fish
.
The previously described hurricane damages reduced the annual aggregate processing capacity to approximately 850,000 tons as of June 30, 2008. The Company
anticipates that the decrease in annual processing capacity will have no effect on the Companys ability to process in the future because the Company has historically operated at processing levels substantially below maximum capacity.
Operations at the Cameron fish processing facility were re-established in June 2006, but at reduced processing capabilities. The Cameron facility became fully operational in September 2006.
Because of the damages to the Companys Cameron, Louisiana facility caused by Hurricane Rita, the Company began its 2006 fishing season by operating
its full contingent of 30 Gulf of Mexico fishing and carry vessels out of its two operating facilities in Abbeville, Louisiana and Moss Point, Mississippi. These activities substantially increased the number of vessels at the Abbeville and Moss
Point plants to a level that the Company had not operated previously. Although these two facilities had adequate processing capacity, the Companys fishing efforts were diminished because increased unloading time due to additional vessels
reduced the number of vessels on the fishing grounds during the most optimal fishing times. During June 2006, 10 vessels were shifted to the Cameron facility when it became operational.
Distribution System
. The Companys distribution system of warehouses, tank storage facilities, vessel loading facilities, trucks, barges and
railcars allows the Company to service customers throughout the United States and also foreign locations. The Company owns and leases warehouses and tank storage space for storage of its products, generally at terminals along the Mississippi River.
The Company generally contracts with third-party trucking, vessel, barge and railcar companies to transport its products to and from warehouses and tank storage facilities and directly to its customers.
Historically, approximately 35% to 40% of Omegas FAQ grade fish meal was sold on a two-to-twelve-month forward contract basis. The balance of FAQ
grade fish meal and other products was substantially sold on a spot basis through purchase orders. In 2002, the Company began a similar forward sales program for its specialty grade meals and crude fish oil due to increasing demand for these
products. During 2005, 2006 and 2007 approximately 70%, 70% and 50%, respectively, of the Companys specialty meals and crude fish oil had been sold on a forward contract basis. Prior to the beginning of the Companys 2008 fishing season,
approximately 68% and 56% of the Companys 2008 forecasted fish meal and crude fish oil, respectively, had either been sold or sold forward on a contract basis. The percentage of fish meal and crude fish oil sold on a forward contract basis
will fluctuate from year to year based upon perceived market availability.
29
OMEGA PROTEIN CORPORATION
The Companys annual revenues are highly dependent on annual fish catch, production yields and inventories and, in
addition, inventory is generally carried over from one year to the next year. The Company determines the level of inventory to be carried over based on prevailing market prices of the products and anticipated customer usage and demand during the
off-season. Thus, production volume does not necessarily correlate with sales volume in the same year and sales volumes will fluctuate from quarter to quarter. The Companys fish meal products have a useable life of approximately one year from
date of production. Practically, however, the Company attempts to empty its warehouses of the previous seasons products by the second or third month of the new fishing season. The Companys crude fish oil products do not lose efficacy
unless exposed to oxygen and, therefore, their storage life typically is longer than that of fish meal.
The following table sets forth the
Companys revenues by product (in millions) and the approximate percentage of total revenues represented thereby, for the indicated periods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30,
|
|
|
Six Months Ended June 30,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
Revenues
|
|
Percent
|
|
|
Revenues
|
|
Percent
|
|
|
Revenues
|
|
Percent
|
|
|
Revenues
|
|
Percent
|
|
Regular Grade
|
|
$
|
5.5
|
|
11.7
|
%
|
|
$
|
4.6
|
|
12.3
|
%
|
|
$
|
11.3
|
|
13.5
|
%
|
|
$
|
8.7
|
|
12.7
|
%
|
Special Select
|
|
|
14.3
|
|
30.4
|
|
|
|
22.4
|
|
60.4
|
|
|
|
30.5
|
|
36.7
|
|
|
|
37.4
|
|
54.8
|
|
Sea-Lac
|
|
|
3.5
|
|
7.4
|
|
|
|
1.4
|
|
3.8
|
|
|
|
7.1
|
|
8.5
|
|
|
|
3.0
|
|
4.4
|
|
Crude Oil
|
|
|
17.8
|
|
37.8
|
|
|
|
4.3
|
|
11.6
|
|
|
|
21.8
|
|
26.2
|
|
|
|
11.3
|
|
16.6
|
|
Refined Oil
|
|
|
4.8
|
|
10.2
|
|
|
|
3.4
|
|
9.2
|
|
|
|
10.2
|
|
12.3
|
|
|
|
6.2
|
|
9.1
|
|
Fish Solubles
|
|
|
1.2
|
|
2.5
|
|
|
|
0.8
|
|
2.2
|
|
|
|
2.3
|
|
2.8
|
|
|
|
1.4
|
|
2.1
|
|
Other
|
|
|
|
|
|
|
|
|
0.2
|
|
0.5
|
|
|
|
|
|
|
|
|
|
0.2
|
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
47.1
|
|
100.0
|
%
|
|
$
|
37.1
|
|
100.0
|
%
|
|
$
|
83.2
|
|
100.0
|
%
|
|
$
|
68.2
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customers and Marketing.
Most of the Companys marine protein products are sold
directly to approximately 600 customers by the Companys agriproducts sales department, while a smaller amount is sold through independent sales agents. Product inventory was $39.6 million as of June 30, 2008 versus $58.0 million as of
December 31, 2007.
The Companys fish meal is sold primarily to domestic feed producers for utilization as a high-protein
ingredient for the swine, aquaculture, dairy and pet food industries. Crude fish oil sales primarily involve export markets where the fish oil is used for aquaculture feeds. Over the past decade, increasing percentages of the Companys fish
meal and oil products have been sold into the aquaculture industry. The growth of the worldwide aquaculture industry has resulted in increasing demand for fish oils and meals to improve feed efficiency, nutritional value and health of farm-raised
fish species.
The Companys products are sold both in the U.S. and internationally. International sales consist mainly of fish oil
sales to Norway, Canada, Chile and Japan. The Companys sales in these foreign markets are denominated in U.S. dollars and are not directly affected by currency fluctuations. Such sales could be adversely affected by changes in demand resulting
from fluctuations in currency exchange rates.
A number of countries in which the Company currently sells products impose various tariffs
and duties, none of which have a significant impact on the Companys foreign sales. Certain of these duties have been reduced in recent years for certain countries under the North American Free Trade Agreement and the Uruguay Round Agreement of
the General Agreement on Tariffs and Trade. In all cases, the Companys products are shipped to its customers either by FOB shipping point or CIF terms, and therefore, the customer is responsible for any tariffs, duties or other levies imposed
on the Companys products sold into these markets.
30
OMEGA PROTEIN CORPORATION
During the off season, the Company fills purchase orders from the inventory it has accumulated during the fishing season or
in some cases, by re-selling meal purchased from other suppliers. Prices for the Companys products tend to be lower during the fishing season when product is more abundant than in the off season. Throughout the entire year, prices are often
significantly influenced by supply and demand in world markets for competing products, primarily other global sources of fish meal and oil, and also soybean meal for its fish meal products, and vegetable oils for its fish oil products when used as
an alternative.
Quality Control
. The Company believes that maintaining high standards of quality in all aspects of its
manufacturing operations play an important part in its ability to attract and retain customers and maintain its competitive position. To that end, the Company has adopted strict quality control systems and procedures designed to test the quality
aspects of its products, such as protein content and digestibility. The Company regularly reviews, updates and modifies these systems and procedures as appropriate.
Purchases and Sales of Third-Party Meal and Oils
. Omega has from time to time purchased fish meal and fish oil from other domestic and international manufacturers. These purchase and resale transactions have to
date been ancillary to the Companys base manufacturing and sales business.
During 2005 and 2006, the Companys fish catch and
resultant product inventories were reduced, primarily due to adverse weather conditions, and the Company further expanded its purchase and resale of other fish meals and oils (primarily Panamanian, Peruvian and Mexican fish meal and U.S. menhaden
oil). Although operating margins from these activities are less than the margins typically generated from the Companys base domestic production, these operations provide the Company with a source of fish meal and oil to sell into other
markets, some of which, the Company has not historically had a presence. During 2005, the Company purchased products totaling approximately 16,600 tons, or approximately 8% of total volume 2005 sales. During 2006, the Company purchased products
totaling approximately 14,600 tons, or approximately 7% of total volume 2006 sales. During 2007, the Company purchased fish oil totaling approximately 5,500 tons, or approximately 9.1% of fish oil sales volumes for 2007. The Company has not
purchased any fish meal or fish oil during the six months ended June 30, 2008.
Insurance.
The Company maintains insurance
against physical loss and damage to its assets, coverage against liabilities to third parties it may incur in the course of its operations, as well as workers compensation, United States Longshoremens and Harbor Workers
Compensation Act and Jones Act coverage. Assets are insured at replacement cost, market value or assessed earning power. The Companys limits for liability coverage are statutory or $50 million. The $50 million limit is comprised of several
excess liability policies, which are subject to deductibles, underlying limits, annual aggregates and exclusions. The Company believes its insurance coverage to be in such form, against such risks, for such amounts and subject to such deductibles
and self-retentions as are prudent and normal for its operations. Over recent years, the Company has elected to increase its deductibles and self-retentions in order to achieve lower insurance premium costs. These higher deductibles and
self-retentions have resulted in greater costs to the Company in the cases of Hurricanes Katrina and Rita and will expose the Company to greater risk of loss if additional future claims occur. In addition, the Companys cost of insurance for
property damage has increased materially and may further increase materially in future years as insurers recoup losses paid and to be paid out in connection with Hurricanes Katrina and Rita by charging higher premiums.
Competition.
The Company competes with a smaller domestic privately-owned menhaden fishing company and with international marine protein and oil
producers, including Mexican sardine processors and South American anchovy and mackerel processors. In addition, but to a lesser extent, the Companys marine protein and oil business is also subject to significant competition from producers of
vegetable and other animal protein products and oil products such as Archer Daniels Midland and Cargill. Many of these competitors have significantly greater financial resources and more extensive and diversified operations than those of the
Company.
31
OMEGA PROTEIN CORPORATION
Omega competes on price, quality and performance characteristics of its products, such as protein level and amino acid
profile in the case of fish meal. The principal competition for the Companys fish meal and fish solubles is from other global production of marine proteins as well as other protein sources such as soybean meal and other vegetable or animal
protein products. The Company believes, however, that these other non-marine sources are not complete substitutes because fish meal offers nutritional values not contained in such other sources. Other globally produced fish oils provide the primary
market competition for the Companys fish oil, as well as soybean and rapeseed oil, from time to time.
Fish meal prices have
historically borne a relationship to prevailing soybean meal prices (more weakly correlated in recent years), while prices for fish oil are generally influenced by prices for vegetable fats and oils, such as rapeseed, soybean and palm oils. Thus,
the prices for the Companys products are established by worldwide supply and demand relationships over which the Company has no control and tend to fluctuate significantly over the course of a year and from year to year. For example, during
2007, the Company experienced fish oil price increases of approximately 18% when compared to 2006, whereas palm oil and soy oil prices rose 53% and 66%, respectively. During January 2008, and subsequent thereto, the spot price for fish oil increased
95% above the Companys average price received during 2007.
Price List.
The Company posts its latest internally generated
price list for its various products on its Company website, omegaproteininc.com. The Company expects to post updates to the price list as they become available, which may occur as frequently as weekly. The Company may elect to discontinue this
disclosure at any time without prior notice. Pricing and product availability information disclosed in the price list are subject to change without prior notice, and the Company undertakes no obligation to update such information. Information on the
Companys website is not incorporated by reference into this report and does not constitute part of this report.
Regulation.
The Companys operations are subject to federal, state and local laws and regulations relating to the locations and periods in which fishing may be conducted as well as environmental and safety matters. At the state and local level, certain
state and local government agencies have enacted legislation or regulations which prohibit, restrict or regulate menhaden fishing within their jurisdictional waters.
The Companys menhaden fishing operations are also subject to regulation by two interstate compact commissions created by federal law: the Atlantic States Marine Fisheries Commission (ASMFC) which
consists of 15 states along the Atlantic Coast, and the Gulf States Marine Fisheries Commission which consists of 5 states along the Gulf of Mexico. In 2005, the ASMFC recommended precautionary restrictions on the Chesapeake Bay menhaden harvest,
despite its finding that menhaden are not overfished and that overfishing is not occurring on a coast wide basis, in order to determine whether localized depletion was occurring in Chesapeake Bay.
In February 2007 the Commonwealth of Virginia declined to adopt an ASMFC recommended plan but instead adopted its own restrictions whereby the
Companys Chesapeake Bay menhaden harvest was capped for a five year period at a recent five-year average (2001 to 2005) of 109,020 metric tons per year. The Virginia restrictions also allow for a credit whereby any under-harvest in a
particular year below the 109,020 metric ton cap would be added to increase the cap for the following year, up to a maximum of 122,740 metric tons per year. The Company supported Virginias proposal and voluntarily complied with its limitations
in 2006. This compliance had no effect on the Companys Chesapeake Bay harvest in 2007 and is not expected to have any material adverse effect on its Chesapeake Bay harvest in 2008. As a result of the underharvest in 2007, the 2008 Chesapeake
Bay catch limit will be 122,740 metric tons.
32
OMEGA PROTEIN CORPORATION
On March 27, 2008, the Texas Parks and Wildlife Commission adopted regulations related to the menhaden reduction
fishery in Texas waters which limits the Total Allowable Catch (TAC) to 31.5 million pounds annually (the five year average menhaden catch for reduction purposes in Texas waters from 2002 through 2006). The regulations also allow
for a 10% underage or overage in each year which is credited or deducted, as applicable, to the TAC in the following year.
The
Companys menhaden fish catch in Texas in 2007 is tentatively and preliminarily estimated by the National Marine Fisheries Service to be 35.3 million pounds (approximately 16,000 metric tons), or approximately 2.5% of the Companys
total 2007 fish catch. Based on the Companys understanding of the rule as adopted, the limitation is not expected to have a material adverse effect on the Companys business, results of operation or financial condition. The regulations
are expected to be effective as of the 2009 fishing season.
In October 2007, two bills were introduced in the U.S. House of
Representatives (H.R. 3840 and H.R. 3841) by two congressmen representing portions of New Jersey and Maryland, areas where the Company has no operations. The New Jersey congressman has announced his intention not to seek re-election to Congress in
November 2008 and the Maryland congressman lost the Republican Party primary election for his Congressional district in February 2008, and therefore will not be the Republican nominee for that district in November 2008. The bills, if enacted, would
effectively prohibit commercial fishing for Atlantic menhaden for reduction purposes in inland, state and federal waters along the Atlantic coast. The Company believes that the bills are premised on inaccurate assumptions and depictions of facts
about the menhaden resource which the National Marine Fisheries Service continues to classify as healthy and not overfished. The bills would also supplant decades of fisheries management previously undertaken by the Atlantic States Marine Fisheries
Commission and the National Marine Fisheries Service. The Company believes that the passage of these bills is highly unlikely; however the enactment of either of the bills, or any restrictions similar to those described in the bills, would have a
material adverse effect on the Companys business, results of operations and financial condition.
The Company, through its operation
of fishing vessels, is subject to the jurisdiction of the U.S. Coast Guard, the National Transportation Safety Board and the U.S. Customs Service. The U.S. Coast Guard and the National Transportation Safety Board set safety standards and are
authorized to investigate vessel accidents and recommend improved safety standards. The U.S. Customs Service is authorized to inspect vessels at will.
The Companys operations are subject to federal, state and local laws and regulations relating to the protection of the environment, including the federal Clean Water Act, which imposes strict controls against
the discharge of pollutants in reportable quantities, and along with the Oil Pollution Act, imposes substantial liability for the costs of oil removal, remediation and damages. The Companys operations also are subject to the federal Clean Air
Act, as amended; the federal Comprehensive Environmental Response, Compensation, and Liability Act, which imposes liability, without regard to fault, on certain classes of persons that contributed to the release of any hazardous
substances into the environment; and the federal Occupational Safety and Health Act (OSHA). The implementation of continuing safety and environmental regulations from these authorities could result in additional requirements and
procedures for the Company, and it is possible that the costs of these requirements and procedures could be material.
The OSHA hazard
communications standard, the Environmental Protection Agency community right-to-know regulations under Title III of the federal Superfund Amendment and Reauthorization Act and similar state statutes require the Company to organize information about
hazardous materials used or produced in its operations. Certain of this information must be provided to employees, state and local governmental authorities and local citizens. Numerous other environmental laws and regulations, along with similar
state laws, also apply to the operations of the Company, and all such laws and regulations are subject to change.
33
OMEGA PROTEIN CORPORATION
The Company has made, and anticipates that it will make in the future, expenditures in the ordinary course of its business
in connection with environmental matters. Such expenditures have not been material in the past, and while they are expected to increase in the future, such increases are not expected to be material to the Companys overall business. However,
there is no assurance that environmental laws and regulations enacted in the future will not require material expenditures or otherwise adversely affect the Companys operations.
The Company continually monitors regulations which affect fish meal and fish oil in the United States and in those foreign jurisdictions where it sells
its products. In some cases, particularly in Europe, regulators have mandated various environmental contaminant levels which, on occasion, certain of the Companys products do not meet. In those instances, the Company has either negotiated a
lower price with the customer for that product lot or has sold the product lot in another market where the regulatory standards are met. To date, such regulations have not had a material adverse effect on the Companys business, but it is
possible they may do so in the future.
The Companys harvesting operations are subject to the Shipping Act of 1916 and the
regulations promulgated thereunder by the Department of Transportation, Maritime Administration which require, among other things, that the Company be incorporated under the laws of the U.S. or a state, the Companys chief executive officer be
a U.S. citizen, no more of the Companys directors be non-citizens than a minority of the number necessary to constitute a quorum and at least 75% of the Companys outstanding capital stock (including a majority of the Companys
voting capital stock) be owned by U.S. citizens. If the Company fails to observe any of these requirements, it will not be eligible to conduct its harvesting activities in U.S. jurisdictional waters. Such a loss of eligibility would have a material
adverse effect on the Companys business, results of operations and financial condition.
To protect against such loss of eligibility,
the Companys Articles of Incorporation (i) contain provisions limiting the aggregate percentage ownership by non-citizens of each class of the Companys capital stock to no more than 25% of the outstanding shares of each such class
(the Permitted Percentage) so that any purported transfer to non-citizens of shares in excess of the Permitted Percentage will be ineffective as against the Company for all purposes (including for purposes of voting, dividends and any
other distribution, upon liquidation or otherwise), (ii) provide for a dual stock certificate system to determine such ownership pursuant to which certificates representing shares of Company Common Stock bear legends that designate such
certificates as either citizen or non-citizen depending on the citizenship of the owner, and (iii) permit the Companys Board of Directors to make such determinations as may reasonably be necessary to ascertain such
ownership and implement restrictive limitations on those shares that exceed the Permitted Percentage (the Excess Shares). For example, the Companys Board is authorized, among other things, to redeem for cash (upon written notice)
any Excess Shares in order to reduce the aggregate ownership by non-citizens to the Permitted Percentage.
Available Information
The Company files annual, quarterly and current reports and other information with the SEC. The Companys annual reports on Form 10-K, quarterly
reports on Form 10-Q, current reports on Form 8-K and amendments to these reports filed under the Securities and Exchange Act of 1934 (Exchange Act), as well as Section 16 filings by officers and directors, are available free of
charge at the Companys website at
www.omegaproteininc.com
or at the SECs website at
www.sec.gov
and are posted as soon as reasonably practicable after they are filed with the SEC. The Company will provide a copy of these
documents to stockholders upon request. Information on the Companys website or any other website is not incorporated by reference into this report and does not constitute part of this report.
34
OMEGA PROTEIN CORPORATION
In addition, the public may read and copy any materials filed by the Company with the SEC at the SECs Public Reference
Room at 100 F. Street, NE., Washington, DC 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains a website that contains reports, proxy and information
statements, and other information regarding issuers that file electronically with the SEC at
www.sec.gov
.
The Companys
Corporate Governance Guidelines, Code of Business Conduct and Ethics, Code of Ethics for Financial Professionals, as well as the Charters for the Boards Audit Committee, Compensation Committee, Corporate Governance Committee and Scientific
Committee, are available at the Companys website. These Guidelines, Codes and Charters are not incorporated by reference into this report and do not constitute part of this report. The Company will provide a copy of these documents to
stockholders upon request.
Critical Accounting Policies and Estimates
As expected, the adoption of SFAS No. 157 did not have a material impact on the Companys consolidated results of operation and financial position.
For information on critical accounting policies and estimates, see Note 1 to the unaudited condensed consolidated financial statements included in
Item 1 Financial Statements.
Results of Operations
The following table sets forth as a percentage of revenues certain items of the Companys operations for each of the indicated periods.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30,
|
|
|
Six Months Ended
June 30,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
Revenues
|
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
Cost of sales
|
|
66.2
|
|
|
76.3
|
|
|
70.9
|
|
|
77.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
33.8
|
|
|
23.7
|
|
|
29.1
|
|
|
22.1
|
|
Selling, general and administrative expense
|
|
8.5
|
|
|
9.0
|
|
|
9.3
|
|
|
12.0
|
|
Research and development expense
|
|
0.7
|
|
|
0.5
|
|
|
0.8
|
|
|
0.6
|
|
(Gain) loss on disposal of assets
|
|
(0.1
|
)
|
|
0.5
|
|
|
0.2
|
|
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
24.7
|
|
|
13.7
|
|
|
18.8
|
|
|
9.2
|
|
Interest income
|
|
0.3
|
|
|
0.2
|
|
|
0.4
|
|
|
0.2
|
|
Interest expense
|
|
(2.1
|
)
|
|
(3.4
|
)
|
|
(2.7
|
)
|
|
(4.3
|
)
|
Loss resulting from debt refinancing
|
|
|
|
|
|
|
|
|
|
|
(4.4
|
)
|
Other income (expense), net
|
|
(0.1
|
)
|
|
(0.2
|
)
|
|
(0.1
|
)
|
|
(0.3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
22.8
|
|
|
10.3
|
|
|
16.4
|
|
|
0.4
|
|
Provision for income taxes
|
|
8.6
|
|
|
3.5
|
|
|
6.0
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
14.2
|
%
|
|
6.8
|
%
|
|
10.4
|
%
|
|
0.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interim Results for the Second Quarters ended June 30, 2008 and June 30, 2007
Revenues
. Revenues increased $10.0 million, or 27.1%, from $37.1 million for the three months ended June 30, 2007 to
$47.1 million for the three months ended June 30, 2008. The increase in revenues was due to higher sales prices of 1.1% and 62.8% for the Companys fish meal and fish oil, respectively, and higher sales volumes of 81.5% for the
Companys fish oil, which was partially offset by lower sales volumes of 18.8% for the Companys fish meal. Considering fish meal, fish oil and fish solubles sales activities in total, the Company experienced a $7.4 million increase in
revenues due to increased sales prices and a $2.6 million increase in revenue caused by increased sales volumes, when comparing the three months ended June 30, 2008 to the three months ended June 30, 2007.
35
OMEGA PROTEIN CORPORATION
Cost of Sales
. Cost of sales, including depreciation and amortization, for the quarter ended June 30,
2008 was $31.2 million, a $2.9 million increase, or 10.3%, as compared to the quarter ended June 30, 2007. Cost of sales as a percentage of revenues was 66.2% for the quarter ended June 30, 2008 as compared to 76.3% for the quarter ended
June 30, 2007. The decrease in cost of sales as percentage of revenue was primarily due to increased fish oil sales prices, partially offset by increased per unit production costs due to increased labor and repair costs.
Gross Profit
. Gross profit increased $7.1 million, or 81.1%, from $8.8 million for the quarter ended June 30, 2007 to $15.9 million
for the quarter ended June 30, 2008. Gross profit as a percentage of revenues was 33.8% for the quarter ended June 30, 2008 as compared to 23.7% for the quarter ended June 30, 2007. The increase in gross profit was primarily due to
increased fish oil sales prices partially offset by increased per unit production costs as discussed above.
Selling, general and
administrative expenses
. Selling, general and administrative expenses increased $0.7 million, or 19.3%, from $3.3 million for the quarter ended June 30, 2007 to $4.0 million for the quarter ended June 30, 2008. The increase was
primarily due to increased employee bonuses and government relations activities incurred during the quarter ended June 30, 2008 when compared to those incurred during the quarter ended June 30, 2007.
Research and development expenses
. Research and development expenses increased $0.1 million from approximately $0.2 million for the three
months ended June 30, 2007 to approximately $0.3 million for the three months ended June 30, 2008. The increase is due to the increase in equipment and employees for the OmegaPure Technology and Innovation Center, which commenced
operations in January 2007 but was not fully staffed until the latter part of 2007.
(Gain) loss on disposal of assets
. Gain
on disposal of assets was $32,000 for the three months ended June 30, 2008 as compared to a loss on disposal of assets of $184,000 for the three months ended June 30, 2007. The (gain) loss were the result of disposals of miscellaneous
assets in the ordinary course of business.
Operating income
.
As a result of the factors discussed above, the
Companys operating income increased $6.5 million from $5.1 million for the quarter ended June 30, 2007 to $11.6 million for the quarter ended June 30, 2008. As a percentage of revenues, operating income increased from 13.7% for the
quarter ended June 30, 2007 to 24.7% for the quarter ended June 30, 2008.
Interest income
. Interest income
increased by $89,000 from $56,000 for the three months ended June 30, 2007 to $145,000 for the three months ended June 30, 2008. The increase was primarily due to increased average cash balances on which interest income is generated
partially offset by a decrease in interest rates.
Interest expense
. Interest expense decreased $0.3 million, or 22.3%, from
$1.3 million for the quarter ended June 30, 2007 to $1.0 million for the quarter ended June 30, 2008. The decrease in interest expense is primarily due to decreased debt balances and interest rates during the quarter ended June 30,
2008 as compared to the quarter ended June 30, 2007.
Other income (expense), net
. Other income (expense), net decreased
by $1,000 from $69,000 for the quarter ended June 30, 2007 to $68,000 for the quarter ended June 30, 2008. The decrease was primarily due to a decrease in fees paid to the Companys bank and related lenders.
36
OMEGA PROTEIN CORPORATION
Provision for income taxes
. The Company recorded a $4.0 million provision for income taxes for the quarter
ended June 30, 2008 representing an effective tax rate of 37.5% for income taxes compared to 34.0% for the quarter ended June 30, 2007. The increase in the effective tax rate is the result of the Companys expected taxable income and
related statutory tax bracket. The Company believes that it is more probable than not that the recorded estimated deferred tax asset benefits and state operating loss carry-forwards will be realized except for the amount for which a valuation
allowance has been provided. The statutory tax rate of 35% and 34% for U.S. federal taxes was in effect for the three month periods ended June 30, 2008 and 2007, respectively.
Interim Results for the Six Months ended June 30, 2008 and June 30, 2007
Revenues
. Revenues increased $15.0 million, or 22.0%, from $68.2 million for the six month period ended June 30, 2007 to $83.2 million
for the six month period ended June 30, 2008. The increase in revenues was due to higher sales prices of 3.6% and 56.2% for the Companys fish meal and fish oil, respectively, and higher sales volumes of 16.9% for the Companys fish
oil, which was partially offset by lower sales volumes of 3.9% for the Companys fish meal. Considering fish meal, fish oil and fish solubles sales activities in total, the Company experienced a $13.3 million increase in revenues due to
increased sales prices and a $1.7 million increase in revenue caused by increased sales volumes, when comparing the six month period ended June 30, 2008 to the six month period ended June 30, 2007.
Cost of Sales
. Cost of sales, including depreciation and amortization, for the six month period ended June 30, 2008 was $59.1 million,
a $5.9 million increase, or 11.1%, as compared to the six month period ended June 30, 2007. Cost of sales as a percentage of revenues was 70.9% for the six month period ended June 30, 2008 as compared to 77.9% for the six month period
ended June 30, 2007. The decrease in cost of sales as percentage of revenue was primarily due to increased fish oil sales prices, partially offset by increased per unit production costs due to increased labor and repair costs.
Gross Profit
. Gross profit increased $9.1 million, or 60.6%, from $15.1 million for the six month period ended June 30, 2007 to $24.2
million for the six month period ended June 30, 2008. Gross profit as a percentage of revenues was 29.1% for the six month period ended June 30, 2008 as compared to 22.1% for the six month period ended June 30, 2007. The increase in
gross profit was primarily due to increased fish oil sales prices partially offset by increased per unit production costs as discussed above.
Selling, general and administrative expenses
. Selling, general and administrative expenses decreased $0.5 million, or 6.3%, from $8.2 million for the six month period ended June 30, 2007 to $7.7 million for the six month
period ended June 30, 2008. The decrease was primarily due to decreased employee bonuses, partially offset by increased government relations activities during the six month period ended June 30, 2008, as compared to the six month period
ended June 30, 2007.
Research and development expenses
. Research and development expenses increased $0.3 million from
approximately $0.4 million for the six month period ended June 30, 2007 to approximately $0.7 million for the six month period ended June 30, 2008. The increase is due to the increase in equipment and employees for the OmegaPure Technology
and Innovation Center, which commenced operations in January 2007 but wasnt fully staffed until latter part of 2007.
(Gain)
loss on disposal of assets
. Loss on disposal of assets was $0.2 million for the six month period ended June 30, 2008 and 2007. The losses were the result of disposals of miscellaneous assets in the ordinary course of business.
37
OMEGA PROTEIN CORPORATION
Operating income
.
As a result of the factors discussed above, the Companys operating
income increased $9.4 million from $6.3 million for the six month period ended June 30, 2007 to $15.7 million for the six month period ended June 30, 2008. As a percentage of revenues, operating income increased from 9.2% for the six month
period ended June 30, 2007 to 18.8% for the six month period ended June 30, 2008.
Interest income
. Interest income
increased by $0.2 million from $0.1 million for the six month period ended June 30, 2007 to $0.3 million for the six month period ended June 30, 2008. The increase was primarily due to increased average cash balances on which interest
income is generated partially offset by a decrease in interest rates.
Interest expense
. Interest expense decreased $0.7
million, or 25.3%, from $2.9 million for the six month period ended June 30, 2007 to $2.2 million for the six month period ended June 30, 2008. The decrease in interest expense is primarily due to decreased debt balances and interest rates
during the six month period ended June 30, 2008 as compared to the six month period ended June 30, 2007.
Loss resulting
from debt refinancing
.
Loss resulting from debt refinancing was $3.0 million for the six month period ended June 30, 2007. The expenses relate to previously deferred debt issuance cost and other costs that became
immediately recognized when the Company refinanced its prior credit facility on March 26, 2007. No such loss was incurred during the six month period ended June 30, 2008.
Other income (expense), net
. Other income (expense), net decreased by $0.1 million from $0.2 million for the six month period ended
June 30, 2007 to $0.1 million for the six month period ended June 30, 2008. The decrease was primarily due to a decrease in fees paid to the Companys bank and related lenders.
Provision for income taxes
. The Company recorded a $5.0 million provision for income taxes for the six month period ended June 30,
2008 representing an effective tax rate of 36.9% for income taxes compared to 33.9% for the six month period ended June 30, 2007. The increase in the effective tax rate is the result of the Companys expected taxable income and related
statutory tax bracket. The Company believes that it is more probable than not that the recorded estimated deferred tax asset benefits and state operating loss carry-forwards will be realized except for the amount for which a valuation allowance has
been provided. The statutory tax rate of 35% and 34% for U.S. federal taxes was in effect for the six month periods ended June 30, 2008 and 2007, respectively.
Seasonal and Quarterly Results
The Companys menhaden harvesting and processing business is
seasonal in nature. The Company generally has higher sales during the menhaden harvesting season (which includes the second and third quarter of each year) due to increased product availability, but prices during the fishing season tend to be lower
than during the off-season. Additionally, due to the sharp increase in fish oil prices during 2008 and the resultant increase in gross profit margins for those products, any variation in the mix of product sales between quarters may result in
significant variations of total gross profit margins. As a result, the Companys quarterly operating results have fluctuated in the past and may fluctuate in the future. In addition, from time to time the Company defers sales of inventory based
on worldwide prices for competing products that affect prices for the Companys products which may affect comparable period comparisons.
Liquidity
and Capital Resources
Historically, the Companys primary sources of liquidity and capital resources have been cash flows from
operations, bank credit facilities and term loans from various lenders provided pursuant to the U.S. Maritime Administrations Fisheries Finance Program (FFP), which is offered through National Marine Fisheries Services
38
OMEGA PROTEIN CORPORATION
(NMFS) under Title XI of the Marine Act of 1936 (Title XI). These sources of cash flows have been used for operations, capital
expenditures, payment of long-term debt and the purchase and retirement of shares of the Companys common stock in 2006.
At
June 30, 2008, the Company had an unrestricted cash balance of $23.8 million, up $4.5 million from December 31, 2007. This increase was primarily due to increased revenue and proceeds received from stock options exercised for the six
months ended June 30, 2008, offset by capital expenditures and costs incurred related to the preparation for the 2008 fishing season. The Companys annual revenues and its resulting liquidity are highly dependent on annual fish catch,
production yields, selling prices for its products and inventories available for sale. While the Companys fish catch and selling prices for its products increased in 2007 and 2006 over 2005, those increases were offset by very poor fish oil
yields during 2006, which resulted in significantly higher per unit inventory costs and fewer volumes of fish oil available for future sale. These higher costs and lower volumes of fish oil available for sale adversely impacted the financial results
in the first and second quarters of 2007. There was no similar impact in the third and fourth quarters of 2007 and first and second quarters of 2008.
The aggregate amount of the Companys outstanding indebtedness at June 30, 2008 was approximately $62.1 million compared to approximately $65.3 million at December 31, 2007. The Company has a moderately
leveraged financial structure, which could limit its financial flexibility in certain circumstances. In particular, the Company will be required to use a portion of its cash flows to pay principal and interest on its debt, which will reduce the
amount of money the Company has for operations, capital expenditures, expansion, acquisitions or general corporate or other business activities. In addition, the covenants contained in the Companys debt agreements limit its ability to borrow
money in the future for acquisitions, capital expenditures or to meet the Companys operating expenses or other general corporate obligations. See Risk Factors - The Company has a substantial amount of indebtedness, which may adversely
affect its ability to operate its business, remain in compliance with debt covenants and make payments on its debt.
Source of Capital: Operations
Net cash flow (used in) provided by operating activities increased from approximately ($0.3) million for the six month period ended
June 30, 2007 to $10.2 million for the six month period ended June 30, 2008. The increase in operating cash flow is primarily attributable to net income and changes in accounts receivable, inventory, accrued liabilities and accounts
payable. Additionally, the Company incurred an early payment penalty of $0.9 million during the six month period ended June 30, 2007 related to the Company refinancing its prior credit facility.
Source of Capital: Debt
Net financing activities
provided (used) cash of $7.0 million and ($5.6) million during the six month periods ended June 30, 2008 and 2007, respectively. The six month period ended June 30, 2008 included $3.2 million in debt principal payments and $10.2 million in
proceeds and tax effects received from stock options exercised. The six month period ended June 30, 2007 included approximately $43.4 million in total borrowings, $51.0 million in principal payments with respect to the Companys prior
credit facility and other debt obligations, $0.7 million in debt issuance costs associated with the new Senior Credit Facility and $2.7 million in proceeds and tax effects received from stock options exercised.
Under Title XI, as administered under the FFP, the Company has secured loans through lenders with terms generally ranging between 12 and 20 years at
interest rates between 6% and 8% per annum which are enhanced with a government guaranty to the lender for up to 80% of the financing. The Companys current Title XI borrowings are secured by liens on certain fishing vessels and mortgages
on the Companys Reedville, Virginia and Abbeville, Louisiana plants. In 1996, Title XI borrowing was modified to permit use of proceeds from borrowings obtained through this program for shore-side construction.
39
OMEGA PROTEIN CORPORATION
In September 2004, the FFP approved the Companys financing application in an amount not to exceed $14.0 million (the
Approval Letter). Borrowings under the Approval Letter are required to be used to finance and/or refinance approximately 73% of the actual depreciable cost of the Companys future fishing vessel refurbishments and capital
expenditures relating to shore-side fishing assets, for a term not to exceed 15 years from inception at interest rates determined by the U.S. Treasury. Final approval for all such future projects requires individual approval through the Secretary of
Commerce, National Oceanic and Atmospheric Administration, and NMFS. Borrowings under the FFP are required to be evidenced by security agreements, undertakings, and other documents deemed in the sole discretion of the NMFS as necessary to accomplish
the intent and purpose of the Approval Letter. The Company is required to comply with customary NMFS covenants as well as certain special covenants. The Company closed on a $14.0 million FFP loan on October 17, 2005.
On December 1, 2005, pursuant to the Title XI program, the FFP approved a second financing application made by the Company in the amount of $16.4
million (the Second Approval Letter). In May 2006, the Company submitted a $6.3 million financing request under the Second Approval Letter. The Company closed on the $6.3 financing in the first quarter of 2007. As of June 30, 2008,
the Company had approximately $29.7 million of borrowings outstanding under Title XI and was in compliance with all of the covenants contained therein.
On March 26, 2007 (the Closing Date), the Company entered into a Credit Agreement (the Credit Agreement) with Bank of America, N.A., as administrative agent, lender, swing line lender and
letter of credit issuer, Regions Bank, Compass Bank and Farm Credit Bank of Texas (collectively, the Lenders). The Credit Agreement provides the Company with a $55 million senior credit facility (the Senior Credit Facility)
consisting of (i) a 5-year revolving credit facility (the Revolving Credit Facility) of up to $20 million, including a $7.5 million sub-limit for the issuance of standby letters of credit and a $2.5 million sub-limit for swing line
loans and (ii) a 5-year term loan (the Term Loan) of $35 million. The Senior Credit Facility replaced the Companys prior credit facility, under which, as of the Closing Date, $28.7 million in principal was outstanding under a
term loan and $6.5 million in principal was outstanding under revolving loans, and approximately $3.3 million in letters of credit were issued, primarily in support of workers compensation insurance programs. On the Closing Date, the Company
drew down $35 million under the Term Loan and approximately $2.0 million under the Revolving Credit Facility, and had approximately $3.1 million issued in standby letters of credit, primarily in support of workers compensation insurance
programs. The Senior Credit Facility is secured by a first priority lien on all of the Companys assets, other than vessels, real estate and other assets pledged to secure loans made to the Company under the FFP.
Aggregate amounts outstanding under the Revolving Credit Facility (including standby letters of credit and swing line loans) are limited to an amount not
to exceed the lesser of (i) $20 million and (ii) an amount equal to the sum of (a) 80% of Eligible Accounts Receivable (as defined in the Credit Agreement) plus (b) 50% of net book value of Eligible Inventory (as defined in the
Credit Agreement), provided that Eligible Inventory shall not comprise more than 50% of the total of (a) and (b). Standby letters of credit will be issued by, and swing line loans will be made available by, Bank of America, N.A. and each Lender
will purchase an irrevocable and unconditional participation in each standby letters of credit and swing line loan, subject to certain conditions. Swing line loans will be made available on a same day basis in minimum amounts of $100,000, subject to
certain conditions.
Any loan (other than swing line loans) under the Senior Credit Facility bears interest at a rate equal to the
Applicable Margin, as determined in accordance with the pricing grid set forth below, plus one of the following indexes: (i) Eurodollar and (ii) the Base Rate (defined as the higher of (a) the Federal Funds Rate plus 0.50% and (b) the
rate of interest in effect for such day as publicly announced from time to time by Bank of America as its prime rate). Each swing line loan bears interest at the Base Rate plus the Applicable Margin for Base Rate loans.
40
OMEGA PROTEIN CORPORATION
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated
Leverage Ratio of
the Company and
its Subsidiaries
|
|
Applicable
Commitment
Fee
|
|
|
Letters of Credit
Fee
|
|
|
Applicable
Margin for
Eurodollar
Loans
|
|
|
Applicable
Margin for
Base Rate
Loans
|
|
Less than 2.0x
|
|
0.40
|
%
|
|
2.00
|
%
|
|
2.00
|
%
|
|
0.50
|
%
|
Less than 2.50x but greater than or equal to 2.0x
|
|
0.40
|
%
|
|
2.25
|
%
|
|
2.25
|
%
|
|
0.75
|
%
|
Less than 3.0x but greater than or equal to 2.5x
|
|
0.40
|
%
|
|
2.38
|
%
|
|
2.38
|
%
|
|
1.00
|
%
|
Less than 3.5x but greater than or equal to 3.0x
|
|
0.40
|
%
|
|
2.50
|
%
|
|
2.50
|
%
|
|
1.25
|
%
|
Greater than or equal to 3.5x
|
|
0.50
|
%
|
|
2.75
|
%
|
|
2.75
|
%
|
|
1.50
|
%
|
All borrowings made on the Closing Date were made as Base Rate loans. These Base Rate loans were
converted to Eurodollar loans three days after the Closing Date.
The Company entered into interest rate swap agreements with a notional
amount as indicated below that are scheduled to mature in March 2012. Under these agreements, the Company receives a floating rate based on the LIBOR interest rate, and pays a fixed rate as indicated below on the various notional amounts.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of Contract
|
|
Original
Notional
Amount
|
|
Contracted
Interest
Rate
|
|
|
Total Asset
(Liability) as of
June 30, 2008
|
|
|
Total Deferred
Tax Asset
(Liability) as of
June 30, 2008
|
|
|
Notional
Amount as of
June 30, 2008
|
April 4, 2007
|
|
$
|
19,950,000
|
|
5.16
|
%
|
|
$
|
(630,800
|
)
|
|
$
|
214,500
|
|
|
$
|
18,453,800
|
February 7, 2008
|
|
|
10,237,500
|
|
3.36
|
%
|
|
|
111,000
|
|
|
|
(37,700
|
)
|
|
|
9,712,500
|
March 19, 2008
|
|
|
4,436,250
|
|
2.96
|
%
|
|
|
90,700
|
|
|
|
(30,800
|
)
|
|
|
4,208,700
|
The Credit Agreement requires the Company comply with various affirmative and negative covenants
affecting its business and operations. In addition, the Company is required to comply with the following financial covenants:
|
|
|
The Company is required to maintain Consolidated Net Worth (as defined in the Credit Agreement) of at least $85,000,000, which is increased on a cumulative basis as
of the end of each fiscal quarter (commencing June 30, 2007) by an amount equal to 75% of Consolidated Net Income (as defined in the Credit Agreement) (to the extent positive) for the fiscal quarter then ended plus 100% of the amount of certain
equity issuances after the Closing Date that increase consolidated shareholders equity.
|
|
|
|
The Company is required to maintain, as of the end of each fiscal quarter (commenced March 31, 2007), a Consolidated Leverage Ratio (as defined in the Credit
Agreement) of 4.0 to 1.0, which will be reduced to (i) 3.75 to 1.0 on September 30, 2007, (ii) 3.25 to 1.0 on December 31, 2007, (iii) 3.0 to 1.0 on December 31, 2008, (iv) 2.75 to 1.0 on December 31, 2009 and
(iv) 2.5 to 1.0 on December 31, 2010 for thereafter.
|
|
|
|
The Company is required to maintain, as of the end of each fiscal quarter (commenced March 31, 2007), a Consolidated Fixed Charge Coverage Ratio (as defined in
the Credit Agreement) of at least 1.1 to 1.0.
|
41
OMEGA PROTEIN CORPORATION
|
|
|
The Company is required to maintain, at the end of each fiscal quarter (commenced March 31, 2007), a Consolidated Asset Coverage Ratio (as defined in the
Credit Agreement) of 1.5 to 1.0, which will be increased to 2.0 to 1.0 on December 31, 2008 for thereafter.
|
|
|
|
The Company is not permitted to have Consolidated Capital Expenditures (as defined in the Credit Agreement) in excess of $15 million for any fiscal year.
|
As of June 30, 2008, the Company was in compliance with all applicable financial covenants.
The Senior Credit Facility will terminate on March 26, 2012 (the Maturity Date). All loans and all other obligations outstanding under
the Senior Credit Facility shall be payable in full on the Maturity Date. For a more detailed description of the terms and conditions of the Credit Agreement, see the Companys Current Report on Form 8-K filed with the SEC on March 30,
2007.
As of June 30, 2008, the Company had $32.4 million outstanding under the Term Loan and approximately $2.8 million in letters of
credit issued primarily in support of workers compensation insurance programs. As of June 30, 2008, the Company had $13.1 million available under the Revolving Credit Facility and the Company was in compliance with all of the covenants
under the Senior Credit Facility. The Company has no off-balance sheet arrangements other than normal operating leases and standby letters of credit.
Use of Capital: Operations
Net investing activities (used) provided cash of ($12.7) million and $1.8 million for the six
month periods ended June 30, 2008 and 2007, respectively. The Companys investing activities consist mainly of capital expenditures for equipment purchases, replacements, vessel refurbishments, and fish oil refining processes. The Company
made capital expenditures of approximately $12.8 million and $4.8 million, for the six month periods ended June 30, 2008 and 2007, respectively. The Company anticipates making an additional $3.3 million in capital expenditures during the
remainder of 2008 primarily for the refurbishment of vessels and plant assets and for the repair of certain equipment. Investing activities also includes the receipt of $0.1 million related to proceeds from disposition of assets for the six month
period ended June 30, 2008, and $6.5 million from insurance companies relating to Hurricanes Katrina and Rita for the six month period ended June 30, 2007.
The Company believes that the existing cash, cash equivalents, short-term investments, cash flow from operations and funds available through the Senior Credit Facility and/or Title XI indebtedness described above will
be sufficient to meet its working capital and capital expenditure requirements through at least the next twelve months.
Use of Capital: Acquisitions
The Company from time to time considers potential transactions including, but not limited to, enhancement of physical facilities to
improve production capabilities and the acquisition of other businesses. Certain of the potential transactions reviewed by the Company would, if completed, result in its entering new lines of business (generally including certain businesses to which
the Company sells its products such as pet food manufacturers, aquaculture feed manufacturers, fertilizer companies and organic foods manufacturers and distributors), although historically, reviewed opportunities have been generally related in some
manner to the Companys existing operations or which would have added new protein products to the Companys product lines. Although the Company does not explicitly budget for acquisitions and, as of the date hereof, does not have any
commitment with respect to a material acquisition, it could enter into such agreement in the future. Depending on the size of the acquisition, the Company would expect to finance the transaction using internally generated cash flows and its Senior
Credit Facility, or, if necessary, equity or debt financings. The Company cannot assure that such financings will be available on acceptable terms, if at all.
42
OMEGA PROTEIN CORPORATION
Use of Capital: Contractual Obligations
The following tables aggregate information about the Companys contractual cash obligations and other commercial commitments (in thousands) as of June 30, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Period
|
Contractual Cash Obligations
|
|
Total
|
|
Less than
1 year
|
|
1 to 3
years
|
|
4 to 5
years
|
|
After 5
years
|
Long term debt
|
|
$
|
62,075
|
|
$
|
6,983
|
|
$
|
17,937
|
|
$
|
20,032
|
|
$
|
17,123
|
Capital lease obligation
|
|
|
1,027
|
|
|
137
|
|
|
374
|
|
|
516
|
|
|
|
Interest on long term debt and capital lease obligation
|
|
|
18,870
|
|
|
4,128
|
|
|
6,681
|
|
|
3,671
|
|
|
4,390
|
Operating lease obligations
|
|
|
7,136
|
|
|
1,925
|
|
|
2,127
|
|
|
1,456
|
|
|
1,628
|
Pension funding
|
|
|
3,386
|
|
|
497
|
|
|
1,505
|
|
|
1,314
|
|
|
70
|
Standby letters of credit
(1)
|
|
|
2,815
|
|
|
2,815
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Contractual Cash Obligations
|
|
$
|
95,309
|
|
$
|
16,485
|
|
$
|
28,624
|
|
$
|
26,989
|
|
$
|
23,211
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
As of June 30, 2008, the Company had $2.8 million in standby letters of credit under the Senior Credit Facility.
|
Subsequent to June 30, 2008, the Company committed to purchase portions of its expected natural gas usage totaling $1.7 million which will be
utilized during the remainder of the 2008 fishing season and $1.2 million which will be utilized during the 2009 fishing season.
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
In the normal course of business, the financial condition of the Company is exposed to minimal market risk associated with interest rate movements on the Companys borrowings. To further mitigate this minimal risk, the Company has
entered into interest rate swap agreements to effectively lock-in the LIBOR component of certain debt instruments. A one percent increase or decrease in the levels of interest rates on variable rate debt would not result in a material change to the
Companys results of operations.
The Company is also exposed to market risk associated with natural gas and diesel prices. Partially
mitigating this risk, the Company purchased natural gas call options which gave the Company the right to purchase natural gas at a price of $10.50 per MMBTU between April 1, 2008 and June 30, 2008. The Company is currently exposed to
market risk associated with increases in natural gas prices. No similar transactions have been obtained for diesel.
Although the Company
sells products in foreign countries, all of the Companys revenues are billed and paid for in US dollars. As a result, management does not believe that the Company is exposed to any significant foreign country currency exchange risk, and the
Company does not utilize market risk sensitive instruments to manage its exposure to this risk.
43
OMEGA PROTEIN CORPORATION
Item 4.
|
Controls and Procedures.
|
(a) Evaluation of
Disclosure Controls and Procedures
As of the end of the period covered by this report, the Company conducted an evaluation of the
effectiveness of its disclosure controls and procedures, as that phrase is defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934. The evaluation was carried out under the supervision and with the participation
of management, including the Companys Chief Executive Office (CEO) and Chief Financial Officer (CFO).
Based
on and as of the date of that evaluation, the Companys CEO and CFO have concluded that (i) the Companys disclosure controls and procedures are designed to ensure that information required to be included by the Company in the reports
that the Company files or submits to the Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, is recorded, processed, summarized and reported within the time periods specified in the SECs rules and
forms, and that such information is accumulated and communicated to the Companys management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure, and (ii) that the Companys disclosure
controls and procedures are effective.
Notwithstanding the foregoing, there can be no assurance that the Companys disclosure
controls and procedures will detect or uncover all failures of persons within the Company and its consolidated subsidiaries to disclose material information otherwise required to be set forth in the Companys periodic reports. There are
inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure
controls and procedures can only provide reasonable, not absolute, assurance of achieving their control objectives.
(b) Changes in
Internal Controls
There were no changes in the Companys internal controls over financial reporting during the period covered by this
report that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting.
44
OMEGA PROTEIN CORPORATION
PART II. OTHER INFORMATION
Item 1.
|
Legal Proceedings
|
The Company is defending various
claims and litigation arising from operations which arise in the ordinary course of the Companys business. In the opinion of management, any losses resulting from these matters will not have a material adverse affect on the Companys
results of operations, cash flows or financial position.
Risk Factors and Significant Factors That May
Affect Forward-Looking Statements
The Company cautions investors that the following risk factors, and those factors described elsewhere
in this Report, other filings by the Company with the SEC from time to time and press releases issued by the Company, could affect the Companys actual results which could differ materially from those expressed in any forward-looking statements
made by or on behalf of the Company.
The risks described below are not the only ones facing the Company. The Companys business is
also subject to other risks and uncertainties that affect many other companies, such as competition, technological obsolescence, labor relations (including risks of strikes), general economic conditions and geopolitical events. Additional risks not
currently known to the Company or risks that the Company currently believes are immaterial may also impair the Companys business, results of operations and financial results.
Risks Relating to the Companys Business and Industry:
The Company is dependent on a single natural resource
and may not be able to catch the amount of menhaden that it requires to operate profitably.
The Companys primary raw material is menhaden. The Companys business is totally dependent on its annual menhaden harvest in ocean waters
along the U.S. Atlantic and Gulf coasts. The Companys ability to meet its raw material requirements through its annual menhaden harvest fluctuates from year to year and month to month, due to natural conditions over which the Company has no
control. These natural conditions, which include varying fish population, adverse weather conditions and fish disease, may prevent the Company from catching the amount of menhaden required to operate profitably.
The Companys operations are geographically concentrated in the Gulf of Mexico where they are susceptible to regional adverse weather patterns such as
hurricanes.
Three of the Companys four operating plants are located in the Gulf of Mexico (two in Louisiana and one in Mississippi), a region which has historically been subject to a late summer/early fall hurricane season. The
Companys Virginia facility has in the past also at times been adversely affected by hurricanes. All three of the Companys Gulf of Mexico plants were severely damaged within a one-month span by Hurricanes Katrina and Rita in August and
September 2005. Immediately after the second hurricane, approximately 70% of the Companys 2004 production capacity was impaired and the Companys business, results of operations and financial condition were materially adversely affected.
Additional future weather related disruptions could, if they occur, also have a material adverse effect on the Companys business, results of operations and financial condition. In addition, the Companys costs of insurance for property
damage have increased as insurers recoup losses paid and to be paid out in connection with the Katrina and Rita hurricanes by charging higher premiums.
The costs of energy may materially impact the Companys business.
The Company has experienced
45
OMEGA PROTEIN CORPORATION
substantially higher costs for energy in recent years. The Companys business is materially dependent on diesel fuel for its vessels and natural gas for
its operating facilities. The costs of these commodities, which are beyond the Companys control, may have an adverse material impact on the Companys business, results of operations and financial condition.
Fluctuation in oil yields derived from the Companys fish catch could impact the Companys ability to operate profitably.
The oil
yield, or the percentage of oil derived from the menhaden fish, while it is relatively high compared to many species of fish, has fluctuated over the years and from month to month due to natural conditions relating to fish biology over which
the Company has no control. The oil yield has at times materially impacted the amount of fish oil that the Company has been able to produce from its available fish catch and it is possible that oil yields in the future could also adversely impact
the Companys ability to operate profitably.
The Companys fish oil yields can vary.
For example, the Companys oil yields for the
2006 fishing season were lower by 28% compared to those in the 2005 fishing season and were lower by 24% compared to the Companys 10 year oil yield average. The Company believes that the causes of lower fish oil yields relate to fish diet,
weather and water temperature but such causes are not generally well understood. Poor oil yields result in significantly higher per unit inventory costs and fewer volumes available for future sale.
Laws or regulations that restrict or prohibit menhaden or purse seine fishing operations could adversely affect the Companys ability to operate.
The
adoption of new laws or regulations at federal, regional, state or local levels that restrict or prohibit menhaden or purse seine fishing operations, or stricter interpretations of existing laws or regulations, could materially adversely affect the
Companys business, results of operations and financial condition. In addition, the impact of a violation by the Company of federal, regional, state or local law or regulation relating to its fishing operations, the protection of the
environment or the health and safety of its employees could have a material adverse affect on the Companys business, results of operations and financial condition.
One example of potentially restrictive regulation is an addendum to a fisheries management plan recommended by a regional regulatory commission in August 2005. The Commonwealth of Virginia has declined to adopt the
regulatory commissions recommended plan but has instead adopted its own restrictions whereby the Companys Chesapeake Bay menhaden harvest would be capped for a five year period at a recent five-year average (2001 to 2005) of 109,020
metric tons per year. The Virginia restrictions also allow for a credit whereby any under-harvest in a particular year below the 109,020 metric ton cap would be added to increase the cap for the following year, up to a maximum of 122,740 metric tons
per year. The Company supported Virginias proposal and voluntarily complied with its limitations in 2006. This compliance had no effect on the Companys Chesapeake Bay harvest in 2007 and is not expected to have a material adverse effect
on the Chesapeake Bay harvest in 2008. As a result of the 2007 Chesapeake Bays underharvest, the 2008 Chesapeake Bay catch limit will be 122,740 metric tons. The regulations are expected to be effective commencing with the 2009 fishing season.
On March 27, 2008, the Texas Parks and Wildlife Commission adopted regulations related to the menhaden reduction fishery in Texas waters which limits
the Total Allowable Catch (TAC) to 31.5 million pounds annually (the five year average menhaden catch for reduction purposes in Texas waters from 2002 through 2006). The regulations also allow for a 10% underage or overage in each
year which is credited or deducted, as applicable, to the TAC in the following year.
The Companys menhaden fish catch in Texas in 2007 is
tentatively and preliminarily estimated by the National Marine Fisheries Service to be 35.3 million pounds (approximately 16,000 metric tons), or
46
OMEGA PROTEIN CORPORATION
approximately 2.5% of the Companys total 2007 fish catch. Based on the Companys understanding of the rule as adopted, the limitation is not
expected to have a material adverse effect on the Companys business, results of operation or financial condition.
In October 2007, two bills were
introduced in the U.S. House of Representatives (H.R. 3840 and H.R. 3841) by two congressmen representing portions of New Jersey and Maryland, areas where the Company has no operations. The New Jersey congressman has announced his intention not to
seek re-election to Congress in November in November 2008 and the Maryland congressman lost the Republican Party primary election for his Congressional district in February 2008, and therefore will not be the Republican nominee for that district in
November 2008. The bills, if enacted, would effectively prohibit commercial fishing for Atlantic menhaden for reduction purposes in inland, state and federal waters along the Atlantic coast. The Company believes that the bills are premised on
inaccurate assumptions and depictions of facts about the menhaden resource which the National Marine Fisheries Service continues to classify as healthy and not overfished. The bills would also supplant decades of fisheries management previously
undertaken by the Atlantic States Marine Fisheries Commission and the National Marine Fisheries Service. The Company believes that the passage of these bills is highly unlikely; however the enactment of either of the bills, or any restrictions
similar to those described in the bills, would have a material adverse effect on the Companys business, results of operations and financial condition.
The Companys fish catch may be impacted by restrictions on its spotter aircraft.
If the Companys spotter aircraft are prohibited or restricted from operating in their normal manner during the Companys fishing
season, the Companys business, results of operations and financial condition could be adversely affected. For example, as a direct result of the September 11, 2001 terrorist attacks, the Secretary of Transportation issued a federal ground
stop order that grounded certain aircraft (including the Companys fish-spotting aircraft) for approximately nine days. This loss of spotter aircraft coverage severely hampered the Companys ability to locate menhaden fish during this
nine-day period and thereby reduced its amount of saleable product.
Worldwide supply and demand relationships, which are beyond the Companys
control, influence the prices that the Company receives for many of its products and may from time to time result in low prices for many of the Companys products.
Prices for many of the Companys products are subject to, or influenced
by, worldwide supply and demand relationships over which the Company has no control and which tend to fluctuate to a significant extent over the course of a year and from year to year. The factors that influence these supply and demand relationships
are world supplies of fish meal made from other fish species, animal proteins and fats, palm oil, rapeseed oil, soy meal and oil, and other edible oils.
New laws or regulation regarding contaminants in fish oil or fish meal may increase the Companys cost of production or cause the Company to lose business.
It is possible that future enactment of increasingly stringent
regulations regarding contaminants in fish meal or fish oil by foreign countries or the United States may adversely affect the Companys business, results of operations and financial condition. More stringent regulations could result in:
(i) the Companys incurrence of additional capital expenditures on contaminant reduction technology in order to meet the requirements of those jurisdictions, and possibly higher production costs for Companys products, or
(ii) the Companys withdrawal from marketing its products in those jurisdictions.
Risks Relating to the Companys Ongoing Operations:
The Company has a substantial amount of indebtedness, which may adversely affect its ability to operate its business, remain in compliance with debt
covenants and make payments on its debt.
As of
47
OMEGA PROTEIN CORPORATION
June 30, 2008, the aggregate amount of the Companys outstanding indebtedness under its Senior Credit Facility and its loan agreements under the
Title XI Fisheries Finance Program was approximately $62.1 million. The Companys outstanding indebtedness could have important consequences for you, including the following:
|
|
|
it may be more difficult for the Company to satisfy its obligations with respect to its Senior Credit Facility and its loan agreements under the Title XI Fisheries
Finance Program, and any failure to comply with the obligations of any of the agreements governing such indebtedness, including financial and other restrictive covenants, could result in an event of default under such agreements;
|
|
|
|
the covenants contained in the Companys debt agreements limit its ability to borrow money in the future for acquisitions, capital expenditures or to meet its
operating expenses or other general corporate obligations;
|
|
|
|
the amount of the Companys interest expense may increase because certain of its borrowings are at variable rates of interest, which, if interest rates
increase, could result in higher interest expense;
|
|
|
|
the Company will need to use a portion of its cash flows to pay principal and interest on its debt, which will reduce the amount of money the Company has for
operations, working capital, capital expenditures, expansion, acquisitions or general corporate or other business activities;
|
|
|
|
the Company may have a higher level of debt than some of its competitors, which could put it at a competitive disadvantage;
|
|
|
|
the Company may be more vulnerable to economic downturns and adverse developments in its industry or the economy in general; and
|
|
|
|
the Companys debt level could limit its flexibility in planning for, or reacting to, changes in its business and the industry in which it operates.
|
The Companys ability to meet its expenses and debt obligations will depend on its future performance, which will be affected by
financial, business, economic, regulatory and other factors. The Company will not be able to control many of these factors, such as economic conditions and governmental regulation. The Company cannot be certain that its earnings will be sufficient
to allow it to pay the principal and interest on its existing or future debt and meet its other obligations. If the Company does not have enough money to service its existing or future debt, it may be required to refinance all or part of its
existing or future debt, sell assets, borrow more money or raise equity. The Company may not be able to refinance its existing or future debt, sell assets, borrow more money or raise equity on terms acceptable to it, if at all.
The Companys strategy to expand into the functional food grade oils market may be unsuccessful.
The Companys attempts to expand its fish oil sales
into the market for refined, functional food grade fish oils for human consumption may not be successful. The Companys expectations regarding future demand for Omega-3 fatty acids may prove to be incorrect or, if future demand does meet the
Companys expectations, it is possible that purchasers could utilize Omega-3 sources other than the Companys products.
The Companys
quarterly operating results will fluctuate as its business is seasonal in nature.
The Companys menhaden harvesting and processing business is seasonal in nature. The Company generally has higher sales during the menhaden harvesting season
(which includes the second and third quarter of each fiscal year) due to increased product availability, but prices during the fishing season tend to be lower than
48
OMEGA PROTEIN CORPORATION
during the off-season. As a result, the Companys quarterly operating results have fluctuated in the past and may fluctuate in the future. In addition,
from time to time the Company defers sales of inventory based on worldwide prices for competing products that affect prices for its products, which may affect comparable period comparisons.
The Companys business is subject to significant competition, and some competitors have significantly greater financial resources and more extensive and
diversified operations than the Company.
The marine protein and oil business is subject to significant competition from producers of vegetable and other animal protein products and oil products such as Archer Daniels Midland and Cargill. In
addition the Company competes with a smaller domestic privately-owned menhaden fishing company and international marine protein and oil producers, including Scandinavian herring processors and South American anchovy and sardine processors. Many of
these competitors have significantly greater financial resources and more extensive and diversified operations than the Company.
The Companys
foreign customers are subject to disruption typical to foreign countries.
The Companys sales of its products in foreign countries are subject to risks associated with foreign countries such as changes in social, political and economic
conditions inherent in foreign operations, including:
|
|
|
Changes in the law and policies that govern foreign investment and international trade in foreign countries;
|
|
|
|
Changes in U.S. laws and regulations relating to foreign investment and trade;
|
|
|
|
Changes in tax or other laws;
|
|
|
|
Partial or total expropriation;
|
|
|
|
Current exchange rate fluctuations;
|
|
|
|
Restrictions on current repatriation; or
|
|
|
|
Political disturbances, insurrection or war.
|
In
addition, it is possible that the Company, at any one time, could have a significant amount of its revenues generated by sales in a particular country which would concentrate the Companys susceptibility to adverse events in that country.
The Company may undertake acquisitions that are unsuccessful and the Companys inability to control the inherent risks of acquiring businesses
could adversely affect its business, results of operations and financial condition operations.
In the future the Company may undertake acquisitions of other businesses, located either in the United States or in other countries, although there
can be no assurances that this will occur. There can be no assurance that the Company will be able (i) to identify and acquire acceptable acquisition candidates on favorable terms, (ii) to profitably manage future businesses it may
acquire, or (iii) to successfully integrate future businesses it may acquire without substantial costs, delays or other problems. Any of these outcomes could have a material adverse effect on the Companys business, results of operations
and financial condition.
The Companys failure to comply with federal U.S. citizenship ownership requirements may prevent it from harvesting
menhaden in the U.S. jurisdictional waters.
The Companys harvesting operations are subject to the Shipping Act of 1916 and the regulations promulgated thereunder by the Department of Transportation, Maritime Administration which require,
among other things, that the Company be incorporated under the laws of the U.S. or a state, the Companys chief executive officer be a U.S. citizen, no more of the Companys directors be non-citizens than a minority of a number necessary
to constitute a quorum and at least 75% of the Companys outstanding capital stock (including a majority of its voting capital stock) be owned by U.S. citizens. If the Company fails to observe any of these requirements, the Company will not be
eligible to conduct its harvesting activities in U.S. jurisdictional waters which would have a material adverse effect on the Companys business, results of operations and financial condition.
49
OMEGA PROTEIN CORPORATION
The Company may not be able to recruit, train and retain qualified marine personnel in sufficient numbers.
The Companys
business is dependent on its ability to recruit, train and retain qualified marine personnel in sufficient numbers such as vessel captains, vessel engineers and other crewmembers. The Company has experienced difficulty in recent years in recruiting
its optimal number of employees. To the extent that the Company is not successful in recruiting, training and retaining employees in sufficient numbers, its productivity may suffer. If the Company were unable to secure a sufficient number of workers
during periods of peak employment, the lack of personnel could have an adverse effect on the Companys business, results of operations and financial condition.
The impact of Hurricanes Katrina and Rita has exacerbated the difficulties of
recruiting and retaining qualified marine personnel in the Gulf Coast area.
The Company has historically participated in the United States H2B Visa
Program whereby foreign nationals are permitted to enter the United States temporarily and engage in seasonal, non-agricultural employment. The Company utilizes its H2B Visa workers for a portion of its fishing vessel crews and plant personnel.
Changes in the H2B Visa Program, the termination of that program, or caps on the number of workers available under that program, could have a material adverse effect upon the Companys ability to secure a sufficient number of workers during
periods of peak employment or cause the Company to bear additional costs to secure domestic workers in a tight job market.
The U.S. Congress has to date
failed to re-authorize the Save Our Small and Seasonal Business Act amendment to the H2B visa program which would allow returning H2B workers from certain prior years from being counted against the H2B visa programs annual 66,000 visa cap.
Because of the relatively low visa cap number, the Company has not received its historical allotment of H2B workers for the 2008 fishing season. Accordingly, the Company is utilizing all domestic workers for its 2008 fishing season. The Company has
changed its recruiting programs to completely replace H2B workers, including raising certain wage scales, implementing sign-on bonuses for certain positions, offering referral fees for qualified workers, and other benefits, all of which have
resulted in additional costs for the Company. In addition, some of the newly hired domestic workers have not worked in the menhaden fishing business prior to working for the Company, unlike many H2B workers who typically return year after year with
the benefits of their training and experience. These newer inexperienced workers have resulted in increased training costs and likely lower productivity for the Companys operations.
The Companys Senior Credit Facility and other Fisheries Finance Program loan agreements contain covenants and restrictions that may limit the Companys
financial flexibility.
The Companys Senior Credit Facility and the Companys loan agreements under the Title XI Fisheries Finance Program contain various covenants and restrictions such as prohibitions on dividends and stock
repurchases without the lenders consent. The Senior Credit Facility also contains various financial covenants that the Company must comply with.
Investment Risks.
Investment risks specifically related to the Companys common stock include:
The limited liquidity for the
Companys common stock could affect your ability to sell your shares at a satisfactory price.
The Companys common stock is relatively illiquid. As of June 30, 2008, the Company had approximately 18.5 million shares of common
stock outstanding. The average daily trading volume in the common stock during the prior 60 calendar days ending on that date was approximately 244,800 shares. A more active public market for the Companys common stock, however, may not
develop, which would continue to adversely affect the trading price and liquidity of the common stock. Moreover, a thin trading market for the common stock causes the market price for the common stock to fluctuate significantly more
50
OMEGA PROTEIN CORPORATION
than the stock market as a whole. Without a large float, the Companys common stock is less liquid than the stock of companies with broader public
ownership and, as a result, the trading prices of the common stock may be more volatile. In addition, in the absence of an active public trading market, you may be unable to liquidate your investment in the Company at a satisfactory price.
Issuance of shares in connection with financing transactions or under stock incentive plans will dilute current stockholders.
Pursuant to the
Companys stock incentive plans, the Companys management is authorized to grant stock awards to its employees, directors and consultants. You will incur dilution upon exercise of any outstanding stock awards. In addition, if the Company
raises additional funds by issuing additional common stock, or securities convertible into or exchangeable or exercisable for common stock, further dilution to its existing stockholders will result, and new investors could have rights superior to
existing stockholders.
The number of shares of the Companys common stock eligible for future sale could adversely affect the market price of its
stock.
The Company had outstanding options to purchase approximately 0.8 million shares of its common stock with a weighted average exercise price of $6.46 per share as of June 30, 2008. These shares of common stock are registered for
resale on currently effective registration statements. In addition, the Company has registered the resale of 5,232,708 shares of common stock that were sold by Zapata to certain purchasers in a private transaction on a currently effective
registration statement. Certain of the Companys officers and directors have also entered into Rule 10b5-1 sales plans with brokers unaffiliated with the Company whereby they have committed to sell automatically and without discretion a
predetermined number of shares of the Companys common stock over a period of time according to their own individual criteria. The Company may issue additional restricted securities or register additional shares of common stock under the
Securities Act in the future. The issuance of a significant number of shares of common stock upon the exercise of stock options, or the availability for sale, or sale, of a substantial number of the shares of common stock eligible for future sale
under effective registration statements, under Rule 144 or otherwise, could adversely affect the market price of the common stock.
The Companys
Articles of Incorporation and Bylaws have provisions that discourage corporate takeovers and could prevent stockholders from realizing a premium on their investment.
Certain provisions of the Companys Articles of Incorporation and Bylaws,
as well as the Nevada Corporation Law, to which the Company is subject, could delay or frustrate the removal of incumbent directors and could make difficult a merger, tender offer or proxy contest involving the Company, even if such events could be
viewed as beneficial by its stockholders. The Companys Board of Directors is empowered to issue preferred stock in one or more series without stockholder action. Any issuance of this blank-check preferred stock could materially limit the
rights of holders of the Companys common stock and render more difficult or discourage an attempt to obtain control of the Company by means of a tender offer, merger, proxy contest or otherwise. In additional, the Articles of Incorporation and
Bylaws contain a number of provisions which could impede a takeover or change in control of the Company, including, among other things, staggered terms for members of its Board of Directors, the requiring of two-thirds vote of stockholders to amend
certain provisions of the Articles of Incorporation or the inability to take action by written consent or to call special stockholder meetings. Certain provisions of the Nevada Corporation Law could also discourage takeover attempts that have not
been approved by the Companys Board of Directors. In addition, federal law requires that at least 75% of the Companys outstanding capital stock be owned by U.S. citizens which will discourage takeover attempts by potential foreign
purchasers.
The Company has not paid dividends and does not expect to pay dividends in the near future.
The Company has never declared or paid any
cash dividends on its common stock since it became a public company in April 1998 and has no intention to do so in the near future. Any determination as to payment of
51
OMEGA PROTEIN CORPORATION
dividends will be made at the discretion of the Companys Board of Directors and will depend upon the Companys operating results, financial
condition, capital requirements, general business conditions and such other factors that the Board of Directors deems relevant. In addition, the payment of cash dividends is not permitted by the terms of the Companys Senior Credit Facility.
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
None
Item 3.
|
Defaults Upon Senior Securities
|
None
Item 4.
|
Submission of Matters to a Vote of Security Holders
|
On May 27, 2008, the Company held its 2008 Annual Meeting of Stockholders. The matters voted on at the meeting and the results of the meeting were as follows:
A. Election of Class I Directors.
The stockholders elected Dr. Gary Allee and Dr. William Lands
III as Class I Directors, with 12,477,474 shares voted for and 112,141 shares that withheld authority for Dr. Allee, and 12,476,771 shares voted for and 112,844 shares that withheld authority for Dr. Lands. There were no broker non-votes.
The Class I Directors terms expire at the 2011 Annual Meeting of Stockholders.
The Class II directors, whose terms expire at the
2009 Annual Meeting of Stockholders, are Gary R. Goodwin and Harry O. Nicodemus, IV. The Class III directors, whose terms expire at the 2010 Annual Meeting of Stockholders, are Paul Kearns and Joseph L. von Rosenberg III.
B. Ratification of Appointment of Independent Registered Public Accounting Firm
The stockholders ratified the appointment of PricewaterhouseCoopers, LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2008, with 12,327,541 shares
voted for, 202,633 shares voted against and 59,441 shares voted abstaining. There were no broker non-votes.
Item 5.
|
Other Information
|
None.
|
|
|
Exhibit No.
|
|
Description of Exhibit
|
31.1
|
|
Rule 13a-14(a)/15d-14(a) Certification for Chief Executive Officer.
|
|
|
31.2
|
|
Rule 13a-14(a)/15d-14(a) Certification for Chief Financial Officer.
|
|
|
32.1
|
|
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for Chief Executive Officer.
|
52
OMEGA PROTEIN CORPORATION
|
|
|
32.2
|
|
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for Chief Financial Officer.
|
*
|
Incorporated by reference
|
53
OMEGA PROTEIN CORPORATION
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
OMEGA PROTEIN CORPORATION
|
|
|
(Registrant)
|
|
|
|
August 7, 2008
|
|
By:
|
|
/s/ ROBERT W. STOCKTON
|
|
|
|
|
(Executive Vice President, Chief Financial Officer)
|
54
Omega Protein (NYSE:OME)
Historical Stock Chart
From Oct 2024 to Nov 2024
Omega Protein (NYSE:OME)
Historical Stock Chart
From Nov 2023 to Nov 2024